<SEC-DOCUMENT>0001213900-24-039226.txt : 20240502
<SEC-HEADER>0001213900-24-039226.hdr.sgml : 20240502
<ACCEPTANCE-DATETIME>20240502171724
ACCESSION NUMBER:		0001213900-24-039226
CONFORMED SUBMISSION TYPE:	POS AM
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20240502
DATE AS OF CHANGE:		20240502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SciSparc Ltd.
		CENTRAL INDEX KEY:			0001611746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		POS AM
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277394
		FILM NUMBER:		24909818

	BUSINESS ADDRESS:	
		STREET 1:		20 RAUL WALLENBERG STREET, TOWER A
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916
		BUSINESS PHONE:		972-3-6103100

	MAIL ADDRESS:	
		STREET 1:		20 RAUL WALLENBERG STREET, TOWER A
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6971916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SciSparc Ltd./ADR
		DATE OF NAME CHANGE:	20210129

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Therapix Biosciences Ltd.
		DATE OF NAME CHANGE:	20140624
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS AM
<SEQUENCE>1
<FILENAME>ea0205137-posam_scisparc.htm
<DESCRIPTION>POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on May 2, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-277394</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Post-Effective Amendment No. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>to</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form F-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCISPARC LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Exact name of registrant as specified in its
charter)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State of Israel</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2834</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State or other jurisdiction of<BR>
incorporation or organization)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary Standard Industrial<BR>
Classification Code Number)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S. Employer<BR>
Identification Number)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20 Raul Wallenberg Street, Tower A, </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel Aviv 6971916, Israel</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (+972) (3) 610-3100</B></P></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Puglisi &amp; Associates</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>850 Library Ave., Suite 204</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Newark, DE 19711</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (302) 738-6680</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Address, including zip
code, and telephone number,<BR>
including area code, of Registrant&rsquo;s principal executive offices)</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Name, address, including zip code, and telephone number,<BR>
 including area code, of agent for service)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Oded Har-Even, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Howard E. Berkenblit, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sullivan &amp; Worcester LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1251 Avenue of the Americas</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10020</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (212) 660-3000</B></P></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Dr. Shachar Hadar, Adv.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Meitar | Law Offices</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>16 Abba Hillel Silver Rd.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Ramat Gan 52506, Israel</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (+972) (3) 610-3100</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public:</B>&nbsp;As soon as practicable after the effective date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.
&#9746;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&nbsp;&#9744;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards &dagger; provided pursuant to Section 7(a)(2)(B) of the Securities
Act. &#9744;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&dagger;</TD><TD STYLE="text-align: justify">The term &ldquo;new or revised financial accounting standard&rdquo;
refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</TD>
</TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>The registrant hereby
amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section
8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant
to said Section 8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Post-Effective Amendment No. 1, or this Post-Effective
Amendment, to the Registration Statement on Form F-1 (File No. 333-277394), or the Registration Statement, is being filed pursuant to
our undertaking in the Registration Statement to update and supplement information contained in the Registration Statement, as originally
declared effective by the Securities and Exchange Commission, or the SEC, on March 6, 2024. The Registration Statement originally covered
<FONT STYLE="background-color: white">the offer and sale of up to</FONT> 5,402,887 ordinary shares, no par value, or Ordinary Shares,
b<FONT STYLE="background-color: white">y YA II PN, LTD., a Cayman Islands exempt limited partnership, or YA or the Selling Shareholder.
The Selling Shareholder is a fund managed by Yorkville Advisors Global, LP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information included in
this filing updates and supplements the Registration Statement and the prospectus contained or incorporated therein. No additional securities
are being registered under this Post-Effective Amendment. Accordingly, this Post-Effective Amendment concerns only the offer and sale
of Ordinary Shares held by YA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All filing fees payable to
the SEC in connection with the registration of these securities were previously paid in connection with the initial filing of the Registration
Statement or prior amendments thereto. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red">The information in this
prospectus is not complete and may be changed. &nbsp;These securities may not be sold until the post-effective amendment to the registration
statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities nor
does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Red">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Red">Subject to Completion,
dated May 2, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 4,422,435 Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SciSparc Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the offer and sale of up to 4,422,435 of our ordinary shares, no par value, or the Ordinary Shares, by YA II PN, LTD., a Cayman Islands
exempt limited partnership, or YA or the Selling Shareholder. The Selling Shareholder is a fund managed by Yorkville Advisors Global,
LP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 21, 2024, we entered
into a Standby Equity Purchase Agreement, as amended on February 26, 2024, or the SEPA, with the Selling Shareholder, which provided for
the sale of up to $20.0 million of our Ordinary Shares. Of the $20.0 million eligible to be sold pursuant to the SEPA, or the Commitment
Amount, to date we have sold 980,452 Ordinary Shares, which includes 55,293 of our Ordinary Shares, or the Commitment Shares, which we
issued in satisfaction of the payment of the commitment fee amount of $200,000. In connection with the SEPA, we may request pre-paid advances
of the Commitment Amount, in an amount up to $5.0 million, each a Pre-Paid Advance. Each Pre-Paid Advance will be evidenced by a promissory
note, each, a Promissory Note. Each Promissory Note will fully mature 24-months following its issuance and shall accrue interest on the
outstanding principal balance thereon at a rate of 5% per annum, increasing to 18% per annum upon an Event of Default (as defined in the
Promissory Note). Beginning 150 days after the issuance of a Promissory Note, we shall pay to YA a monthly installment payment of 10%
of the original principal amount of the Promissory Note and accrued interest, payable in cash or by submitting an Advance Notice, where
YA will offset the amount due to be paid to us under such notice against an equal amount of the monthly installment amount, at our option.
If we elect to pay in cash, the installment amount shall also include a payment premium in the amount of 5% of the principal amount of
the installment payment. The Promissory Note contains our customary representations and warranties and Events of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Ordinary Shares being
offered by the Selling Shareholder may be issued pursuant to the SEPA. We are not selling any securities under this prospectus and will
not receive any of the proceeds from the sale of our Ordinary Shares by the Selling Shareholder. However, we may receive up to $20.0 million
in aggregate gross proceeds from sales of our Ordinary Shares to the Selling Shareholder that we may make under the SEPA, from time to
time after the date of this prospectus. Pursuant to the SEPA, we have issued to the Selling Shareholder an aggregate of 55,293 of our
Ordinary Shares, or the Commitment Shares, in satisfaction of payment of the commitment fee of $200,000. The additional shares that may
be offered pursuant to this prospectus would be purchased by the Selling Shareholder pursuant to the SEPA at 97% of the market price,
which is defined as the lowest daily volume weighted average price of the Ordinary Shares during the three consecutive trading days commencing
on the trading day immediately following our delivery of an advance notice to the Selling Shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder may
sell the Ordinary Shares included in this prospectus in a number of different ways and at varying prices. We provide more information
about how the Selling Shareholder may sell the shares in the section entitled &ldquo;Plan of Distribution.&rdquo; The Selling Shareholder
is an &ldquo;underwriter&rdquo; within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended, or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Shareholder will
pay all brokerage fees and commissions and similar expenses in connection with the offer and sale of the Ordinary Shares by the Selling
Shareholder pursuant to this prospectus. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred
to register under the Securities Act the offer and sale of the Ordinary Shares included in this prospectus by the Selling Shareholder.
See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Ordinary Shares are listed
on the Nasdaq Capital Market, or Nasdaq, under the symbol &ldquo;SPRC&rdquo;. On May 1, 2024, the last reported sale price of our Ordinary
Shares on Nasdaq was $1.37 per share.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 29pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves
risk. See &ldquo;Risk&nbsp;Factors&rdquo; beginning on page 4 of this prospectus and &ldquo;Item 3. &mdash; Key Information &mdash;
D. Risk Factors&rdquo; in our Annual Report on Form 20-F for the year ended December 31, 2023, or the 2023 Annual Report,
incorporated by reference in this prospectus for a discussion of the factors you should consider carefully before deciding to
purchase these securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state or other foreign securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 92%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus Summary</B></FONT></A></TD>
    <TD STYLE="text-align: center">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The Offering</B></FONT></A></TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk Factors</B></FONT></A></TD>
    <TD STYLE="text-align: center">4</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cautionary Note Regarding Forward-Looking Statements</B></FONT></A></TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use of Proceeds</B></FONT></A></TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalization</B></FONT></A></TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Selling Shareholders</B></FONT></A></TD>
    <TD STYLE="text-align: center">23</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of Share Capital</B></FONT></A></TD>
    <TD STYLE="text-align: center">24</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of the Warrants</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research Grants</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan of Distribution</B></FONT></A></TD>
    <TD STYLE="text-align: center">29</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expenses</B></FONT></A></TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal Matters</B></FONT></A></TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Experts</B></FONT></A></TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Enforceability of Civil Liabilities</B></FONT></A></TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify"><A HREF="#pos_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Where You Can Find Additional Information</B></FONT></A></TD>
    <TD STYLE="text-align: center">32</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><A HREF="#pos_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporation of Certain Information by Reference</B></FONT></A></TD>
    <TD STYLE="text-align: center">32</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">You
should rely only on the information contained in this prospectus, including information incorporated by reference herein, and any free
writing prospectus prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Shareholder have authorized
anyone to provide you with information that is different. The Selling Shareholder is offering to sell the securities, and seeking offers
to buy the securities, only in jurisdictions where offers and sales are permitted. The information in this prospectus is accurate only
as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">For
investors outside of the United States: Neither we nor the Selling Shareholder have done anything that would permit this offering or possession
or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You
are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
this prospectus, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; the &ldquo;Company&rdquo; and &ldquo;SciSparc&rdquo; refer to
SciSparc Ltd. and its consolidated subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">All
trademarks or trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks
and trade names in this prospectus are referred to without the&nbsp;<SUP>&reg;</SUP>&nbsp;and&nbsp;<SUP>&trade;</SUP>&nbsp;symbols, but
such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable
law, their rights thereto. We do not intend the use or display of other companies&rsquo; trademarks and trade names to imply a relationship
with, or endorsement or sponsorship of us by, any other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
reporting currency and functional currency is the U.S. dollar.&nbsp;Unless otherwise expressly stated or the context otherwise requires,
references in this prospectus to &ldquo;NIS&rdquo; are to New Israeli Shekels, and references to &ldquo;dollars&rdquo; or &ldquo;$&rdquo;
mean U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
September 28, 2023, we completed a reverse split of our share capital in the ratio of 26:1, or the Reverse Split. Unless the context expressly
indicates otherwise, all references to share and per share amounts referred to herein reflect the amounts after giving effect to the Reverse
Split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus includes statistical, market and industry data and forecasts which we obtained from publicly available information and independent
industry publications and reports that we believe to be reliable sources. These publicly available industry publications and reports generally
state that they obtain their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness
of the information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
report financial information under International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards
Board and none of the financial statements were prepared in accordance with generally accepted accounting principles in the United States.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_001"></A>PROSPECTUS SUMMARY&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>This summary highlights
information contained elsewhere in this prospectus. This summary does not contain all of the information you should consider before investing
in our Ordinary Shares. Before you decide to invest in our Ordinary Shares, you should read the entire prospectus carefully, including
the &ldquo;Risk Factors&rdquo; section, and the financial statements and related notes thereto and the other information incorporated
by reference herein.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are a specialty clinical-stage pharmaceutical company. Our focus is creating and enhancing a portfolio of technologies and assets based
on cannabinoid therapies. With this focus, we are currently engaged in developing and testing pharmaceutical compositions comprised of
N-acylethanolamines and cannabinoids such as Palmitoylethanolamide, or PEA, and/or &Delta;9-tetrahydrocannabinol, or THC, and/or non-psychoactive
cannabidiol, or CBD, and/or other cannabinoid receptor agonists, from which we have derived three main proprietary combinations: SCI-110
for the treatment of Tourette syndrome and Alzheimer&rsquo;s disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for
the treatment of Autism Spectrum Disorder, or ASD. We hold a 50.86% controlling stake in our subsidiary SciSparc Nutraceuticals Inc.,
which focuses on the sale of hemp-based products on Amazon Marketplace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">SCI-110
is a proprietary drug candidate based on two components: (1) THC, which is the major cannabinoid molecule in the cannabis plant, and (2)
CannAmide&trade;, a proprietary Palmitoylethanolamide, or PEA, formulation. PEA is an endogenous fatty acid amide that belongs to the
class of nuclear factor agonists, which are molecules that regulate the expression of genes. We believe that the combination of THC and
PEA may induce a reaction known as the &ldquo;sparing effect,&rdquo; which has strong potential to treat various diseases such as TS and
Alzheimer&rsquo;s disease&nbsp;and agitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">SCI-210
is a proprietary drug candidate based on two components: (1) CBD, and (2) CannAmide&trade;. We believe that the combination of CBD and
PEA may also induce a sparing effect reaction, which has strong potential to treat various diseases such as ASD and SE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">SCI-160
is a novel pharmaceutical preparation containing a cannabinoid receptor type 2, or CB2 receptor, agonist for the treatment of pain. This
innovative CB2 receptor agonist was synthesized by Raphael Mechoulam, Ph.D., Professor of Medicinal Chemistry at the Hebrew University,
a member of the SciSparc Scientific Advisory Board. We believe that modulating CB2 receptor activity by selective CB2 receptor agonists
holds unique therapeutic potential for addressing pain conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the positive results obtained in a phase IIa TS study conducted at Yale School of Medicine, we developed a regulatory dossier that
was submitted to the German Federal Institute for Drugs and Medical Devices, or BfArM, and the Israeli Ministry of Health, or MoH, for
our SCI-110 program for TS. Both agencies approved the program. We plan to submit this regulatory dossier to the U.S. Food and Drug Administration,
or the FDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Standby Equity Purchase
Agreement with YA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 21, 2024, we entered into the SEPA with YA, as amended on February 26, 2024. Pursuant to the SEPA, we will be able to sell up
to $20.0 million of our Ordinary Shares, at our sole option, any time during the three-year period following the execution date of the
SEPA. Of the Commitment Amount, to date we have sold 980,452 Ordinary Shares. Pursuant to the terms of the SEPA, any Ordinary Shares sold
to YA will be priced at 97% of the market price, which is defined as the lowest daily volume weighted average price of the Ordinary Shares
during the three consecutive trading days commencing on the trading day immediately following our delivery of an advance notice to YA,
or the Advance Price. Any sale of Ordinary Shares pursuant to the SEPA is subject to certain limitations, including that YA is not permitted
to purchase any Ordinary Shares that would result in it owning more than 9.99% of our Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>
</DIV>
<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Subject
to certain conditions precedent as described in the SEPA, we may request Pre-Paid Advances. Each Pre-Paid Advance will be evidenced by
a Promissory Note. Each Promissory Note will fully mature 24-months following its issuance and shall accrue interest on the outstanding
principal balance thereon at a rate of 5% per annum, increasing to 18% per annum upon an Event of Default (as defined in the Promissory
Note). Beginning 150 days after the issuance of a Promissory Note, we shall pay to YA a monthly installment payment of 10% of the original
principal amount of the Promissory Note and accrued interest, payable in cash or by submitting an Advance Notice, where YA will offset
the amount due to be paid to us under such notice against an equal amount of the monthly installment amount, at the our option. If we
elect to pay in cash, the installment amount shall also include a payment premium in the amount of 5% of the principal amount of the installment
payment. The Promissory Note contains our customary representations and warranties and Events of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are not obligated to utilize any of the $20.0 million available under the SEPA and there are no minimum commitments or minimum use penalties.
The total amount of funds that ultimately can be raised under the SEPA over the three-year term will depend on the market price for the
Ordinary Shares and the number of Ordinary Shares actually sold. The SEPA does not impose any restrictions on our operating activities.
During the term of the SEPA, YA, and its affiliates, are prohibited from engaging in any short selling or hedging transactions related
to the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, we also agreed to pay YA a commitment fee equal to $200,000, or 1.0% of the aggregate amount available to be sold under the
SEPA, as consideration for its irrevocable commitment to purchase our Ordinary Shares under the SEPA, payable in an amount of our Ordinary
Shares equal to $200,000 divided by the daily volume-weighted average price of the Ordinary Shares on the trading day immediately prior
to the SEPA and also agreed to pay to YA a structuring fee in the amount of $10,000. As satisfaction of the commitment fee, we issued
55,293 of our Ordinary Shares as the Commitment Shares to YA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the SEPA, we were required to register resales of the Ordinary Shares eligible to be sold pursuant to the SEPA and Commitment Shares,
collectively referred to as the Registrable Shares. We agreed to file this registration statement, which was originally declared effective
by the SEC on March 6, 2024, and shall not have the ability to request any advances under the SEPA until the post-effective amendment
to this registration statement, of which this prospectus forms a part, is declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>AutoMax Agreement
and Plan of Merger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April 10, 2024, we entered
into an Agreement and Plan of Merger, or the Merger Agreement, with AutoMax Motors Ltd., an Israeli limited company and a leading&nbsp;vehicle&nbsp;importer
company in Israel, or AutoMax, and SciSparc Merger Sub Ltd., an Israeli limited company and wholly-owned subsidiary of the Company, or
Merger Sub. Upon the terms and subject to the satisfaction of the conditions described in the Merger Agreement, including approval of
the transaction by our shareholders and AutoMax&rsquo;s shareholders, Merger Sub will be merged with and into AutoMax, with AutoMax surviving
the Merger as a wholly-owned subsidiary of the Company, or the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Company Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
legal and commercial name is SciSparc Ltd. We were incorporated in the State of Israel on August 23, 2004, and are subject to the Israeli
Companies Law, 5759-1999, or the Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify; text-indent: 0.4in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Ordinary Shares are listed on Nasdaq under the symbol &ldquo;SPRC&rdquo;. Our principal executive offices are located at 20 Raul Wallenberg
St., Tower A, 2nd Floor, Tel Aviv 6971916 Israel. Our telephone number in Israel is: (+972) (3) 717 5777. Our website address is http://www.scisparc.com.
The information contained on our website or available through our website is not incorporated by reference into and should not be considered
a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B></B></P>
</DIV>
<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding-right: 5pt; padding-left: 5pt; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_002"></A>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares currently outstanding </FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 73%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,097,815 Ordinary Shares. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares offered by the selling shareholder </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Up to 4,422,435 Ordinary Shares that we may sell
    to YA under this SEPA from time to time.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares to be outstanding after this offering<SUP>(1)</SUP></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,520,250 Ordinary Shares, assuming the sale of a total 4,422,435 Ordinary Shares to YA pursuant to the SEPA (at an assumed price per share of $3.74, which is the last reported sales price of our Ordinary Shares on Nasdaq on February 26, 2024).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 26%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds </FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 73%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any proceeds from the sale of the Ordinary Shares included in this prospectus by the Selling Shareholder. We may receive up to $20.0 million aggregate gross proceeds under the SEPA from sales of the Ordinary Shares that we elect to make to YA pursuant to the SEPA, if any, from time to time in our sole discretion, although the actual amount of proceeds that we may receive cannot be determined at this time and will depend on the number of shares we sell under the SEPA and market prices at the times of such sales. In connection with the SEPA, we may request Pre-Paid Advances of the Commitment Amount in an amount up to $5.0 million. Any proceeds that we receive from sales of our Ordinary Shares to YA or Pre-Paid Advances under the SEPA will be used for working capital and general corporate purposes. See &ldquo;Use of Proceeds.&rdquo;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in our securities involves a high degree of risk. You should read the &ldquo;Risk Factors&rdquo; section starting on page 4 of this prospectus, and &ldquo;Item 3. &mdash; Key Information &mdash; D. Risk Factors&rdquo; in our 2023 Annual Report, incorporated by reference herein, and other information included or incorporated by reference in this prospectus for a discussion of factors to consider carefully before deciding to invest in the Ordinary Shares, for a discussion of factors to consider carefully before deciding to invest in the Ordinary Shares.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Ordinary Shares are listed on Nasdaq under symbol &ldquo;SPRC&rdquo;. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of the Ordinary Shares to be outstanding immediately after this offering as shown above assumes that all of the Ordinary Shares
offered hereby are sold and is based on 3,097,815 Ordinary Shares outstanding as of April 30, 2024. This number excludes:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,013 Ordinary Shares issuable upon the exercise of options outstanding under our 2015 Share Option Plan, at a weighted average exercise price of $166.28 per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013,787 Ordinary Shares reserved for issuance and available for future grant under our 2023 Share Option Plan;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,694 Ordinary Shares issuable upon the exercise of outstanding warrants, with exercise prices ranging from $68.38 to $637.0 per Ordinary Share; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,285,000 Ordinary Shares issuable upon the exercise of outstanding pre-funded warrants, with exercise prices ranging from $0.001 to $0.026 per Ordinary Share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 66.5pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 66.5pt; text-align: justify; text-indent: -0.25in"></P>
</DIV>
<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.5pt 0pt 66.5pt; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_003"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Investing in our securities
involves risks. Please carefully consider the risk factors described below and in our periodic reports filed with the SEC, including those
set forth under the caption &ldquo;Item 3. Key Information &ndash; D. Risk Factors&rdquo; in our 2023 Annual Report, which is incorporated
by reference in this prospectus. Before making an investment decision, you should carefully consider these risks as well as other information
we include or incorporate by reference in this prospectus. You should be able to bear a complete loss of your investment.<B>&nbsp;</B></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to an Investment in Our Securities
and this Offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>It is not possible
to predict the actual number of shares we will sell under the SEPA to the Selling Shareholder, or the actual gross proceeds resulting
from those sales.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
January 21, 2024, we entered into the SEPA with YA, pursuant to which YA has committed to purchase up to $20.0 million of our Ordinary
Shares, subject to certain limitations and conditions set forth in the SEPA. Of the Commitment Amount, to date we have not sold any Ordinary
Shares (other than the Commitment Shares). The Ordinary Shares that may be issued under the SEPA may be sold by us to YA at our discretion
from time to time over an approximately 36-month period commencing on the date of the SEPA.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
generally have the right to control the timing and amount of any sales of our Ordinary Shares to YA under the SEPA. Sales of our Ordinary
Shares, if any, to YA under the SEPA will depend upon market conditions and other factors. We may ultimately decide to sell to YA all,
some or none of the Ordinary Shares that may be available for us to sell to YA pursuant to the SEPA.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Because
the purchase price per share to be paid by YA for the Ordinary Shares that we may elect to sell to YA under the SEPA, if any, will fluctuate
based on the market prices of Ordinary Shares during the applicable purchase valuation period for each purchase made pursuant to the SEPA,
if any, it is not possible for us to predict, as of the date of this prospectus and prior to any such sales, the number of Ordinary Shares
that we will sell to YA under the SEPA, the purchase price per share that YA will pay for shares purchased from us under the SEPA, or
the aggregate gross proceeds that we will receive from those purchases by YA under the SEPA, if any.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Moreover,
although the SEPA provides that we may sell up to an aggregate of $20.0 million of our Ordinary Shares to YA, other than the Commitment
Shares only an aggregate of 5,347,594 Ordinary Shares are being registered under this Registration Statement that we may elect to sell
to YA, in our sole discretion, from time to time from and after the date of, and pursuant to, the SEPA. Even if we elect to sell to YA
all of the Ordinary Shares being registered for resale under this prospectus, depending on the market prices of our Ordinary Shares at
the time of such sales, the actual gross proceeds from the sale of all such shares may be substantially less than the $20.0 million total
commitment under the SEPA, which could materially adversely affect our liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If
we desire to issue and sell to YA under the SEPA more than the 4,422,435 Ordinary Shares offered for resale under this prospectus, we
would need to file with the SEC one or more additional registration statements to register under the Securities Act the resale by YA of
any such additional Ordinary Shares and the SEC would have to declare such registration statement or statements effective before we could
sell additional shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Any
issuance and sale by us under the SEPA of a substantial number of Ordinary Shares in addition to the Ordinary Shares being registered
for resale by YA under this prospectus could cause additional substantial dilution to our shareholders. The number of Ordinary Shares
ultimately offered for sale by YA is dependent upon the number of Ordinary Shares, if any, we ultimately sell to YA under the SEPA.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further,
the resale by YA of a significant number of shares registered for resale in this offering at any given time, or the perception that these
sales may occur, could cause the market price of our Ordinary Shares to decline and to be highly volatile.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Investors who buy
shares at different times will likely pay different prices.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the SEPA, we will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold to YA. If and when
we do elect to sell Ordinary Shares to YA pursuant to the SEPA, YA may resell all, some or none of such shares at any time or from time
to time in its discretion and at different prices. As a result, investors who purchase shares from YA in this offering at different times
will likely pay different prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution
and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase from YA
in this offering as a result of future sales made by us to YA at prices lower than the prices such investors paid for their shares in
this offering.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>We may require
additional financing to sustain our operations and without it we will not be able to continue operations.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
extent to which we rely on YA as a source of funding will depend on a number of factors, including the prevailing market price of our
Ordinary Shares, our ability to meet the conditions necessary to deliver advance notices under the SEPA and the extent to which we are
able to secure funding from other sources. Regardless of the amount of funds we ultimately raise under the SEPA, if any, we expect to
continue to seek other sources of funding. Even if we were to sell to YA the total commitment of $20.0 million, of which to date we have
not sold any Ordinary Shares (other than the Commitment Shares), under the SEPA we will still need additional capital to fully implement
our business plan.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Future sales and
issuances of our Ordinary Shares or other securities might result in significant dilution and could cause the price of our Ordinary Shares
to decline.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">To
raise capital, we may sell Ordinary Shares, convertible securities or other equity securities in one or more transactions other than those
contemplated by the SEPA, at prices and in a manner we determine from time to time. We may sell shares or other securities in any other
offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares
or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional
Ordinary Shares, or securities convertible or exchangeable into Ordinary Shares, in future transactions may be higher or lower than the
price per share paid by investors in this offering. Any sales of additional shares will dilute our stockholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Sales
of a substantial number of Ordinary Shares in the public market or the perception that these sales might occur could depress the market
price of our Ordinary Shares and could impair our ability to raise capital through the sale of additional equity securities. We are unable
to predict the effect that sales may have on the prevailing market price of our Ordinary Shares. In addition, the sale of substantial
numbers of our Ordinary Shares could adversely impact their price.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><I>Management will
have broad discretion as to the use of the proceeds from the SEPA or any potential Pre-Paid Advance and uses may not improve our financial
condition or market value.&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Because
we have not designated the amount of net proceeds or potential Pre-Paid Advance from the SEPA to be used for any particular purpose, our
management will have broad discretion as to the application of such proceeds. Our management may use the proceeds for working capital
and general corporate purposes that may not improve our financial condition or advance our business objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Risks Related to the Merger</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the proposed Merger with AutoMax
is not consummated, SciSparc could suffer materially and SciSparc&rsquo;s share price could decline.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
consummation of the proposed Merger with AutoMax is subject to a number of closing conditions, including the approval by ourshareholders
and AutoMax&rsquo;s shareholders, approval by Nasdaq of SciSparc&rsquo;s listing of additional securities application of our ordinary
shares issued in connection with the Merger, and other customary closing conditions. In addition, at the closing date of the Merger, the
net cash held by SciSparc, as described in the Merger Agreement, shall be no less than $4,250,000 (less any amount owned by AutoMax to
SciSparc under any loan agreement between the parties) and the sum of $4,250,000 (less any amount owned by AutoMax to SciSparc under any
loan agreement between the parties). SciSparc is targeting a closing of the transaction in the third quarter of 2024.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">If the proposed Merger is
not consummated, SciSparc may be subject to a number of material risks, and its share price could be adversely affected, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">SciSparc has incurred and expects to continue to incur significant
expenses related to the proposed Merger with AutoMax, even if the Merger is not consummated.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The Merger Agreement contains covenants restricting SciSparc&rsquo;s
solicitation of competing acquisition proposals and the conduct of SciSparc&rsquo;s business between the date of signing the Merger Agreement
and the closing of the Merger. As a result, significant business decisions and transactions before the closing of the Merger require
the consent of AutoMax. Accordingly, SciSparc may be unable to pursue business opportunities that would otherwise be in its best interest
as a standalone company. SciSparc has invested significant time and resources in the transaction process and if the Merger Agreement
is terminated SciSparc will have a limited ability to continue its current operations without obtaining additional financing.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">SciSparc&rsquo;s collaborators and other business partners
and investors in general may view the failure to consummate the Merger as a poor reflection on its business or prospects.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Some of SciSparc&rsquo;s collaborators and other business
partners may seek to change or terminate their relationships with SciSparc as a result of the proposed Merger or the failure thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">As a result of the Merger, current and prospective employees
could experience uncertainty about their future roles within the combined company. This uncertainty may adversely affect SciSparc&rsquo;s
ability to retain its key employees, who may seek other employment opportunities.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">SciSparc&rsquo;s management team may be distracted from day
to day operations as a result of the proposed Merger.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="background-color: white">Nasdaq could determine
to delist </FONT>SciSparc&rsquo;s ordinary shares <FONT STYLE="background-color: white">which could have an adverse effect on the value
of </FONT>SciSparc&rsquo;s ordinary shares <FONT STYLE="background-color: white">and any future ability to raise capital.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, if the Merger
Agreement is terminated and SciSparc&rsquo;s board of directors determines to seek another business combination, it may not be able to
find a third party willing to provide equivalent or more attractive consideration than the consideration to be provided by each party
in the Merger. In such circumstances, SciSparc&rsquo;s board of directors may elect to, among other things, divest all or a portion of
SciSparc&rsquo;s business, or take the steps necessary to liquidate all of SciSparc&rsquo;s business and assets, and in either such case,
the consideration that SciSparc receives may be less attractive than the consideration to be received by SciSparc pursuant to the Merger
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the conditions to the Merger are
not met, the Merger will not occur.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even if the Merger is approved
by the shareholders of SciSparc and AutoMax, specified conditions must be satisfied or waived to complete the Merger. These conditions
are set forth in the Merger Agreement. SciSparc and AutoMax cannot assure you that all of the conditions will be satisfied. If the conditions
are not satisfied or waived, the Merger will not occur or will be delayed, and SciSparc and AutoMax each may lose some or all of the intended
benefits of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some SciSparc and AutoMax officers
and directors have interests in the Merger that are different from yours and that may influence them to support or approve the Merger
without regard to your interests.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain officers and directors
of SciSparc and AutoMax participate in arrangements that provide them with interests in the Merger that are different from yours, including,
among others, the continued service as an officer or director of the combined company, continued indemnification and the potential ability
to sell an increased number of shares of the combined company in accordance with Rule&nbsp;144 under the Securities Act. These interests,
among others, may influence the officers and directors of SciSparc and AutoMax to support or approve the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Merger may be completed even though
material adverse changes may result from the announcement of the Merger, industry-wide changes and other causes.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In general, either party
can refuse to complete the Merger if there is a material adverse change affecting the other party following April 10, 2024, the date of
the Merger Agreement. However, some types of changes do not permit either party to refuse to complete the Merger, even if such changes
would have a material adverse effect on SciSparc or AutoMax, to the extent they resulted from the following (unless, in some cases, they
have a disproportionate effect on SciSparc or AutoMax, as the case may be):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes or conditions generally affecting the industries or
markets in which SciSparc and AutoMax operate, and changes in the industries in which SciSparc and AutoMax operate regardless of geographic
region (including legal and regulatory changes);</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">acts of war, armed hostilities or terrorism;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in financial, banking or securities markets;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any change in, or any compliance with or action taken for
the purpose of complying with, any federal, state, national, foreign, material local or municipal or other law, statute, constitution,
principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted,
promulgated, implemented or otherwise put into effect by or under the authority of any governmental body (including under the authority
of Nasdaq or the Financial Industry Regulatory Authority), or changes in any interpretations thereof;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">any change in U.S. generally accepted accounting principles
or interpretations thereof;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the announcement of the Merger Agreement or the pendency of
the Merger;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the taking of any action required to be taken by the Merger
Agreement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">pandemics, including any worsening thereof, man-made disasters,
natural disasters, acts of God or other force majeure event; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">changes in U.S. or non-U.S. general economic or political
conditions, or in the financial, credit or securities markets in general, including any shutdown of any governmental authority.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If adverse changes occur
but SciSparc and AutoMax must still complete the Merger, the combined company&rsquo;s share price may suffer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market price of the combined company&rsquo;s
shares may decline as a result of the Merger.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of the combined
company&rsquo;s shares may decline as a result of the Merger for a number of reasons, including if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the combined company does not achieve the perceived benefits
of the Merger as rapidly or to the extent anticipated by financial or industry analysts;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the effect of the Merger on the combined company&rsquo;s business
and prospects is not consistent with the expectations of financial or industry analysts; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">investors react negatively to the effect on the combined company&rsquo;s
business and prospects from the Merger.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SciSparc and AutoMax shareholders
may not realize a benefit from the Merger commensurate with the ownership dilution they will experience in connection with the Merger.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the combined company is
unable to realize the strategic and financial benefits currently anticipated from the Merger, SciSparc shareholders will have experienced
substantial dilution of their ownership interest without receiving any commensurate benefit. Significant management attention and resources
will be required to integrate the two companies. Delays in this process could adversely affect the combined company&rsquo;s business,
financial results, financial condition and share price following the Merger. Even if the combined company were able to integrate the business
operations successfully, there can be no assurance that this integration will result in the realization of the full benefits of synergies,
innovation and operational efficiencies that may be possible from this integration and that these benefits will be achieved within a reasonable
period of time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the pendency of the Merger,
SciSparc and AutoMax will be subject to contractual limitations set forth in the Merger Agreement that restrict the parties&rsquo; ability
to enter into business combination transactions with another party.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Covenants in the Merger Agreement
impede the ability of SciSparc or AutoMax to make acquisitions or complete other transactions that are not in the ordinary course of business
pending completion of the Merger. As a result, if the Merger is not completed, the parties may be at a disadvantage to their competitors.
In addition, while the Merger Agreement is in effect and subject to limited exceptions, each party is prohibited from soliciting, initiating,
encouraging or taking actions designed to facilitate any inquiries or the making of any proposal or offer that could lead to the entering
into certain extraordinary transactions with any third party, such as a sale of assets, an acquisition of SciSparc&rsquo;s securities,
a tender offer for SciSparc&rsquo;s securities, a Merger or other business combination outside the ordinary course of business. Any such
transactions could be favorable to such party&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain provisions of the Merger Agreement
may discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the arrangements
contemplated by the Merger Agreement.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of the Merger Agreement
prohibit each of SciSparc and AutoMax from soliciting alternative takeover proposals or cooperating with persons making unsolicited takeover
proposals. Because the lack of a public market for AutoMax shares makes it difficult to evaluate the fairness of the Merger, the shareholders
of AutoMax may receive consideration in the Merger that is less than the fair market value of the AutoMax shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain shareholders could attempt
to influence changes within SciSparc that could adversely affect SciSparc&rsquo;s operations, financial condition and the value of SciSparc&rsquo;s
ordinary shares.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our shareholders may from
time to time seek to acquire a controlling stake in our Company, engage in proxy solicitations, advance shareholder proposals or otherwise
attempt to effect changes. Campaigns by shareholders to effect changes at publicly-traded companies are sometimes led by investors seeking
to increase short-term shareholder value through actions such as financial restructuring, increased debt, special dividends, stock repurchases
or sales of assets or the entire company. Responding to proxy contests and other actions by activist shareholders can be costly and time-consuming
and could disrupt our operations and divert the attention of our board of directors and senior management from the pursuit of the proposed
transaction. These actions could adversely affect our operations, financial condition, our ability to consummate the Merger and the value
of our Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SciSparc and AutoMax may become involved
in securities litigation or shareholder derivative litigation in connection with the Merger, and this could divert the attention of SciSparc
and AutoMax management and harm the combined company&rsquo;s business, and insurance coverage may not be sufficient to cover all related
costs and damages.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Securities litigation or
shareholder derivative litigation frequently follows the announcement of certain significant business transactions, such as the sale of
a business division or announcement of a business combination transaction. SciSparc and AutoMax may become involved in this type of litigation
in connection with the Merger, and the combined company may become involved in this type of litigation in the future. Litigation often
is expensive and diverts management&rsquo;s attention and resources, which could adversely affect the business of SciSparc, AutoMax and
the combined company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the events described in
&ldquo;Risks Related to AutoMax&rsquo;s Business and Operations&rdquo; occur, those events could cause the potential benefits of the Merger
not to be realized.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax&rsquo;s business
is expected to constitute a significant portion of the business of the combined company following the Merger. As a result, the risks described
below in the section entitled &ldquo;Risks Related to AutoMax&rsquo;s Business and Operations&rdquo; beginning on page 9 are among
the most significant risks to the combined company if the Merger is completed. To the extent any of the events in the risks described
in the sections referenced in the previous sentence occur, those events could cause the potential benefits of the Merger not to be realized
and the market price of the combined company&rsquo;s shares to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks Related to AutoMax&rsquo;s Business
and Operations</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax operates in a highly competitive
industry. Failure to develop and execute strategies to remain a preferred importer and seller of vehicles and to adapt to the increasing
use of digital and online tools to market, buy, sell, lease and finance vehicles could adversely affect its business, sales and results
of operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The automotive imports industry
is highly competitive, including publicly and privately owned car importers, which import the same vehicle brands in a variety of models.
The value chain in the automotive industry includes international vehicle manufactures and importers. There are approximately 15 official
import groups in Israel, representing various manufactures, and responsible for approximately 97% of the automotive imports to Israel.
In addition, there are a few dozen parallel importers, who are collectively responsible for approximately 3% of the imports. AutoMax&rsquo;s
competition is dynamic and changes annually based on the selection of vehicles its choses to import and hold in inventory for that year.
AutoMax&rsquo;s selection of product lineup is done annually and determined by a comprehensive analysis of various factors, including
vehicle availability in the importing country, local market demand, tax advantages, currency exchange rates, and other relevant factors.
Certain of AutoMax&rsquo;s competitors have access to more capital than it, which may provide them with an advantage in forging relationships
or providing customers with more competitive prices. Certain car dealers leverage relationships with vehicle manufacturers to sell used
cars as &ldquo;certified pre-owned&rdquo;, which could provide such competitors with an advantage over AutoMax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, competitors
are shifting more focus to online sales, as this is becoming a consumer trend. While AutoMax currently provides online sale services,
there is no guarantee it will be successful in transitioning to online tools, for buying, selling, leasing and financing vehicles which
could adversely affect its business, sales and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The automotive retail industry in general
and AutoMax&rsquo;s business in particular are sensitive to economic conditions. These conditions could adversely affect its business,
sales, results of operations and financial condition. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The automotive retail industry
is sensitive to economic conditions such as inflation rates, increased gas prices, increased import prices, consumer credit availability,
and recessions. The recent historically high global inflation, geopolitical issues, each of the Israel &ndash; Hamas war and Russia &ndash;
Ukraine war, continuous increases in interest rates, unstable global conditions and changes in exchange rates have led to global economic
instability. In 2022, AutoMax witnessed a decrease of approximately 8% in vehicle sales, mainly due to the global chip crisis caused by
the Russia &ndash; Ukraine war. For additional information about the impact of the Israel &ndash; Hamas war on our business and operations,
see &ldquo;&mdash;<I>AutoMax&rsquo;s business and operations face many risks inherent to international maritime trade, and our location
in Israel including the ongoing interplay of the Israel &ndash; Hamas war, may exacerbate the import process, which is material to the
success of our business and operations</I>&rdquo;. The disruption in supply caused a shortage of new vehicles on the market, a longer
waiting period for vehicle delivery, as well as an increase in prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The demand for vehicles could
be affected by such material changes in supply, market prices, exchange rates and general economic conditions. As a result of high inflation
and recession, we are seeing record high levels of interest rates, unemployment and consumer spending trends are changing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Delays or reductions in our
customers&rsquo; purchasing or shifts to lower-cost alternatives that result from tighter economic market conditions, could reduce the
demand for new vehicles and encourage consumers to remain with their current vehicles for longer periods of time, and could, consequently
have a material adverse effect on AutoMax&rsquo;s business, financial condition, and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s business is sensitive to
changes in the prices of new and used vehicles. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax&rsquo;s business is
sensitive to various changes, specifically to changes in the prices of new and used vehicles. A decrease in the prices of new or used
vehicles, due to a reduction in import taxes or a reduced tax for purchasing vehicles could reduce its profit margins. For example, following
an update of the Pollution Regulations and the Procedure for Testing Pollutants in Vehicles in the European Union (WLTP) the Israeli green
taxation formula was updated. Pursuant to such updated taxation formula, the tax benefits in relation to vehicles with a low polluting
level and set tax benefit limits, are gradually decreasing, which causes an increase in the prices of the vehicles that benefited from
the purchase tax. For example, on January 1, 2023, the purchase tax on hybrid vehicles increased from 40% in 2022 to 50%, while the limit
of the tax benefit was reduced from NIS 40,000 in 2021 to NIS 30,000. The purchase tax on electric vehicles was doubled from 10% in 2022
to 20% in 2023, while the limit of the tax benefit was reduced from NIS 75,000 in 2021 to NIS 60,000 in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, in the event
the market becomes open for the free import of vehicles other than through authorized importers of vehicles, it would encourage more companies
to act as indirect importers, which would increase AutoMax&rsquo;s competition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax operates in Israel
and therefore the prices it displays are in NIS, any depreciation of the NIS against foreign currencies in which we purchase vehicles
from manufactures and the reduction of the price of the vehicles by the manufactures or the importers for other reasons, may adversely
affect the value of the vehicles important and marketed by AutoMax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These factors could lead to
a decrease in the value of our inventory, and a decrease in AutoMax&rsquo;s sales, which could adversely affect our business, sales, and
results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s business is sensitive to
changes in consumer preferences and global trends in the automotive industry. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax may be affected by
various global trends and/or events in the environment in which it operates, on which we have no influence ability, which in turn may
affect its operating results. The vehicle manufacturing industry has been characterized in recent years by significant technological progress,
especially in the fields of vehicles driven by alternative energy sources and autonomous vehicles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, there is a noticeable
increase in the cooperative economy trend and a trend of decreasing the environmental damages caused by the use of vehicles, which are
expressed, <I>inter alia</I>, by increase in demand for the use of electric and hybrid vehicles, by the development of new models of vehicle&rsquo;
sharing, by short-term vehicle rentals, in a pay-as-you-go model, and by shared travels. Alongside this, major cities in Europe are promoting
processes intended to reduce and even limit completely the entrance of polluting vehicles into the cities. This trend has recently expanded
to Israel, as part of which, restrictions were imposed on the entry of polluting vehicles into Jerusalem and Haifa, and similar restrictions
are expected to enter into force in Tel Aviv as well.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The developments described
above may create uncertainty in the long term regarding the motorization level as well as the growth rate of the vehicles&rsquo; manufacturing
industry in which manufacturers whose vehicles we import are operating, as well as reducing, in the long term, the demand for car ownership,
which in turn may influence our activity and affect AutoMax&rsquo;s business results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s business and operations
face many risks inherent to international maritime trade, and our location in Israel including the ongoing interplay of the Israel &ndash;
Hamas war, may exacerbate the import process, which is material to the success of our business and operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax imports, distributes
and sells vehicles in Israel, and all the vehicles we sell are manufactured outside of Israel. While AutoMax manages its inventory of
vehicles and spare parts in a manner that allows AutoMax to provide a rapid response to its customers&rsquo; needs, AutoMax&rsquo;s business
remains sensitive to customary risks of importing merchandise, such as currency fluctuations, import duties, trade regulations and restrictions,
transportation costs, unforeseeable disasters, work stoppages, exchange rates, and general political conditions in other countries. Changes
in trade policies could limit AutoMax&rsquo;s ability to import vehicles and/or its ability to purchase vehicles and/or parts at reasonable
prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the foregoing,
there are particular risks to conducting AutoMax&rsquo;s operations in Israel. Following Hamas&rsquo; attack on Israel and Israel&rsquo;s
security cabinet&rsquo;s declaration of war against Hamas, the Houthi movement, which controls parts of Yemen, launched a number of attacks
on marine vessels traversing the Red Sea, which marine vessels were thought to either be in route towards Israel or to be partly owned
by Israeli businesses or persons. The Red Sea is a vital maritime route for international trade traveling to or from Israel. As a result
of such disruptions, and in order to mitigate continued economic harm, suppliers have changed routes from Europe to the Middle East, and,
as a result, AutoMax may experience in the future delays in supplier deliveries, extended lead times, and increased cost of freight, increased
insurance costs, purchased materials and manufacturing labor costs. All of these factors would have an effect on AutoMax, which is substantially
relies on its ability to import and sell vehicles, and such delays and increased costs could have an impact on AutoMax&rsquo;s inventory
which may prevent AutoMax from supplying vehicles in a timely fashion to purchasers and/or impede AutoMax&rsquo;s ability to replenish
its inventory based on consumer trends. Furthermore, such increase in costs could impact AutoMax&rsquo;s ability to sell vehicles at competitive
prices, which could materially affect its financial results and operations. Additionally, some of the main maritime companies have announced
they will no longer make routes to Israel, until such time as it is safe, this could impede on AutoMax&rsquo;s ability to import vehicles,
and as a result could have a material adverse effect on its business and financial results. The risk of ongoing supply disruptions may
further result in delayed deliveries of AutoMax products.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>A decline in available financing may adversely
affect AutoMax&rsquo;s business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of AutoMax&rsquo;s customers
finance their vehicle purchase. As the credit markets have historically experienced volatility and disruption, such downturns could adversely
affect the credit market and affect AutoMax clients&rsquo; ability to secure the required financing. A part of AutoMax&rsquo;s success
is subject to the availability of affordable financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, AutoMax has
non-guaranteed credit lines from four banking corporations, which aggregated to approximately NIS 141.5 million for the year ended December
31, 2022, of which it had utilized approximately NIS 138 million. These credit lines bear interest rates that vary between prime +1% and
prime +2%. If the financial market or the banking system deteriorates, AutoMax&rsquo;s ability to obtain additional financing may be affected.
Such a decline in available financing could have an adverse effect on its business, operations, and financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s ability to import and sell
vehicles depends in large part on agreements with suppliers and, therefore, any disruption or deterioration in its relationship with such
suppliers could impact its business. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax purchases its vehicles
and components from a limited number of suppliers. Disruption or termination of these sources could occur (due to several factors, including,
but not limited to, supplier capacity limitations, bankruptcy, acts of war, terrorism, fire, earthquake). Good relationships with such
distributors are important for AutoMax&rsquo;s business prospects. If AutoMax&rsquo;s relationship with its suppliers were to deteriorate,
or if its suppliers fail to supply vehicles, its business, financial condition, commercialization and results of operations could be materially
adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent years, as a result
of difficulties faced by major vehicle manufacturers, there has been an increase in consolidation of activities and mergers and acquisitions
in the automotive industry, as well as collaborations between vehicle manufacturers. The acquisition of a major supplier by a larger group
may lead to cancellation or non-renewal of franchise agreements, and concentration of the import of brands to Israel under one importer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax&rsquo;s success depends
greatly on its ability to retain and/or recruit suppliers who will provide it with a vehicle inventory, in the scope that will enable
AutoMax to remain competitive in the marketing of vehicles to its customers in Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax is a holding company and as a result
are dependent on its operating subsidiaries to generate sufficient cash to fund its ongoing operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The continuation of AutoMax&rsquo;s
activities depends on its operating subsidiaries&rsquo; ability to generate sufficient cash and raise additional financial sources in
order to develop its activities. The loss of operations or not sufficient operations of its subsidiaries could have a material adverse
effect on its business, sales and results of operations. There is no certainty that AutoMax will succeed in raising funds in the required
amount, or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax is dependent on its management team
and professional personnel, and its business could be harmed if it is unable to attract and retain personnel necessary for its success.
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax&rsquo;s success depends
highly on its ability to attract and retain skilled, professional personnel, consultants and contractors. The departure of highly skilled
professional personnel, in particular any particular key management personnel, could have an adverse impact on AutoMax&rsquo;s operations
and ability to execute its growth plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax&rsquo;s efforts to
retain and attract professional personnel may also result in significant additional expenses, which could adversely affect its profitability.
There can be no assurance that professional personnel will continue to be employed or that we will be able to attract and retain qualified
personnel in the future. Failure to retain or attract qualified personnel could have a material adverse effect on AutoMax&rsquo;s business,
financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to AutoMax&rsquo;s Regulatory
Matters </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s operations are subject to
a wide range of governmental regulations and laws. Its failure to comply with or any changes to these regulations and laws, could adversely
affect AutoMax&rsquo;s business, sales, results of operations and financial condition. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax operates in a highly
regulated industry and it is subject to various local laws and regulations. Additionally, the automotive industry in Israel is characterized
by vast regulation and strict regulatory requirements, including the standardization requirements, which may affect AutoMax&rsquo;s expenditures
and its operational results. Changes in regulatory arrangements that apply to the automotive industry, such as changes in government taxation
policy, changes in the policy regarding the classification of vehicles as private or commercial for tax purposes or changes in the policy
regarding the value of use of a personal vehicle provided by the employer for the use of the employee, or changes in the standards of
vehicles permitted to be imported into Israel, may, in AutoMax&rsquo;s estimation, lead to changes in demand for various types of vehicles,
and affect in the long term the results of its activity. In addition, regulatory changes introduced following the recommendations of the
Committee for the Increase of Competitiveness, as well as changes in the legal provisions that will completely remove or ease the barriers
to entry into the industry, will allow the entry of additional indirect importers, increase competition and, as a result, may cause a
decrease in AutoMax&rsquo;s revenues and profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to renew AutoMax permits and licenses
or their revocation could materially adversely affect its business, results of operations, financial condition and cash flows. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax&rsquo;s subsidiary,
Global Automax Ltd., operates in accordance with and subject to the permits and licenses granted to it for the purpose and within the
framework of its activity as an indirect importer, as further detailed in this prospectus. The main licenses used for the AutoMax operations
are in accordance with the Vehicle Services Licensing Law, Licensing Regulations for Services and Professions in the Automotive Industry
(Vehicle Import and Marketing and Vehicle Trade), 5775-2016 (the &ldquo;Vehicle Services Licensing Law&rdquo;). Since its inception, the
AutoMax subsidiary was granted the required permits and licenses, and these were extended, from time to time, new permits were obtained
when required. However, failure to meet certain criteria as detailed in the Vehicle Services Licensing Law may lead to such permits and
licenses being suspended or not eligible for renewal and/or extensions. Furthermore, such permits could be suspended or revoked until
the required conditions are met. There are currently pending legal proceedings against AutoMax that could, among other things, impede
on its ability to renew or obtain new licenses. For additional information, see <I>&ldquo;&mdash;Risks Related to AutoMax&rsquo;s Regulatory
Matters&mdash;AutoMax is subject to various legal proceedings. If the outcomes of these proceedings are adverse to AutoMax, it could have
a material adverse effect on its business, results of operations and financial condition</I>.&rdquo; Cancellation, conditioning, limitation
or non-renewal of any of the AutoMax licenses, due to the aforementioned reasons or for any other reason, may have an effect on its activities
and business results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Import product restrictions may impair AutoMax&rsquo;s
ability to sell vehicles or parts profitably. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of the spare or replacement
parts AutoMax installs in its vehicles are manufactured outside of Israel. As a result, the AutoMax business is sensitive to customary
risks of importing merchandise, such as import duties, trade regulations and restrictions, transportation costs, unforeseeable disasters,
work stoppages, exchange rates, and general political conditions in other countries. Changes in trade policies could limit AutoMax&rsquo;s
ability to import vehicles and/or its ability to purchase vehicles and/or parts at reasonable prices. Such restrictions could additionally
limit AutoMax&rsquo;s ability to provide servicing for vehicles and decrease its sales and/or attractability for customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, any inability
to receive the required approvals to import its vehicles or any disputes or disagreements with officials regarding the import duties,
tariffs, or similar matters, could adversely affect AutoMax&rsquo;s ability to import vehicles into Israel as well as impact its profit
margins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax is subject to various legal proceedings.
If the outcomes of these proceedings are adverse to AutoMax, it could have a material adverse effect on its business, results of operations
and financial condition. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, AutoMax
or its subsidiaries may be party to legal proceedings and claims in the ordinary course of business. While the outcomes of these matters
cannot be predicted with certainty, AutoMax does not believe they will have a material effect on its consolidated financial position,
results of operations, or cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are currently two pending
legal proceedings against AutoMax, certain beneficial owners as well as officers of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 5, 2021, the Tel
Aviv District Attorney&rsquo;s Office filed an indictment against Global Automax Ltd., Haim Levy Trade-In Ltd., and the following beneficial
owners and officers: Daniel Levy, CEO; Yinon Amit, Chief Business Officer and Director; and Haim Levy, trade manager and the son of Daniel
Levy (the &ldquo;Directors and Officers&rdquo;, together with Global Automax and Haim Levy Trade-In &ldquo;Defendants&rdquo;). Pursuant
to the indictment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Global
Automax was accused of committing forgery offenses according to the Penal Law, fraud under the Penal Law, smuggling according to the
Customs Ordinance [new version] and money laundering offenses, according to the Money Laundering Prohibition Law.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Haim
Levy Trade In was accused of committing forgery offences under the Penal Law, fraud under the Penal Law, smuggling under the Customs
Ordinance, tax and customs violations under the Customs Ordinance (new version), Value Added Tax Law and the Purchase Tax Law (Goods
and Services), and money laundering offenses according to the Prohibition of Money Laundering Law and the Penal Law.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">The Directors and Officers were accused of forgery offences
under the Penal Law, fraud under the Penal Law, smuggling under the Customs Ordinance, and money laundering offenses according to the
Prohibition of Money Laundering Law and the Penal Law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preliminary hearings were
completed, and the evidence trials began in March 2023 for each of the Defendants. AutoMax denies the claims against it, and it should
be noted that the regulations under the Vehicles Services Licensing Law were amended so that importers can purchase vehicles from any
entity. Furthermore, while there were investigations against AutoMax, which were known to the Israeli Ministry of Transport, it renewed
the AutoMax import licenses in accordance with the Vehicles Services Licensing Law and issued AutoMax new import licenses. Furthermore,
the vehicles that are described in the indictment were never released from the customs authority, no import documents were submitted in
their regard, ledgers or tax invoices. Additionally, Global Automax did not continue operating under the license listed in the indictment
and it expired in 2015. The alleged incident was the first operation ever undertaken by Global Automax, and it has since developed its
management and internal regulations to ensure each supplier its works with complies with the respective regulations prior to entering
into any agreement or purchasing vehicles from these.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax believes, based on
the position taken by its legal counsel on this matter, that Global Automax has strong claims in order to deal with the allegations in
the indictment. Furthermore, based on information received from its legal counsel, in the event of a conviction against Global Automax,
the penal sanctions would consist of a monetary fine, and if convicted of money laundering there could be repossessions. In addition,
AutoMax could be exposed to an administrative procedure on behalf of the Israeli Ministry of Transport. Subject to Section 8 of the Vehicle
Services Licensing Law, the Deputy Director General has the authority to refuse granting a license or the renewal of a license, if the
applicant has been convicted of a criminal offense that, due to its nature, severity, or circumstance the applicant is not deemed fit
to provide vehicle services or to provide services in the automotive field for which the application was submitted. The Deputy Director
General has the same authority in the event an indictment was filed, even if a final verdict has not yet been reached. Furthermore, under
Section 10(a)(7) of the Vehicle Services Licensing Law, the Deputy Director General can revoke or suspend a license until the licensee
complies with the conditions put in place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An additional lawsuit was
filed on September 29, 2022, with the District Court in Tel Aviv in the form of a request for approval as a class action against Global
Automax, Union Motors Ltd. (&ldquo;Union&rdquo;), Lex Motors Ltd. (&ldquo;Lex&rdquo;), Toyota Motor Corporation (&ldquo;Toyota&rdquo;),
and Denso Corporation (&ldquo;Denso&rdquo;) (the &ldquo;Request&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The applicant claims that
the defendants (Toyota as a manufacturer of vehicles; Danso as a manufacturer of allegedly defective fuel pumps, installed in Toyota and
Lexus vehicles, and are the subject of the Request. Union and Lex served as direct importers of Toyota and Lexus vehicles in Israel. Global
Automax served as an indirect importer of Toyota vehicles in Israel, and the company that imported the applicant&rsquo;s vehicle to Israel.
The applicant claims that each of Lex, Union and Global Automax, breached their obligations towards the group represented in the class
action, inter alia, producing and/or importing and/or marketing and/or selling vehicles in which a defective fuel pump was installed,
refraining from performing a service recall on all vehicles in which defective pumps were installed, avoided bearing the costs of damages
caused by the defective fuel pumps and the service recall, etc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This, according to the applicant,
is in breach of the defendants&rsquo; obligations according to the Liability for Defective Products Law, 5740-1980, the Sales Law, 5728-1968,
the Contracts Law (General Part), 5733-1973, the Licensing of Services and Professions in the Automotive Industry Law, 5776-2016 and other
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The applicant estimates the
total damages for all members of the claim exceed an aggregate of NIS 2.5 million, and as such that cannot be estimated by him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Global Automax has not yet
submitted a reply to the request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While AutoMax cannot accurately
predict the outcome of this proceeding, it does not believe the claims are substantial and estimate the exposure with respect to such
claim is likely immaterial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s business is subject to a
variety of local and international laws regarding privacy and data protection obligations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax collects, uses, maintains
and otherwise processes certain data about candidates and employees. AutoMax&rsquo;s ability to collect, use, maintain or otherwise process
personal data has been, and could be further, restricted by existing and new laws and regulations relating to privacy and data collection
and protection, including the Israeli Privacy Protection Law, 5741-1981 (the &ldquo;Privacy Law&rdquo;). AutoMax implements measures for
the purpose of adapting the relevant aspects of its activity to the provisions applicable subject to the Privacy Protection Law and the
regulations enacted by virtue thereof, and for this purpose it recently contracted with a company that manages its information security
and privacy protection aspects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in local or foreign tax laws, changing
interpretations of existing tax laws, or adverse determinations by tax authorities could increase AutoMax&rsquo;s tax burden or otherwise
adversely affect its results of operations, and financial condition. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A certain degree of judgment
is required in evaluating its tax positions and determining its provision for income taxes. In the ordinary course of business, there
are many transactions and calculations for which the ultimate tax determination is uncertain. As AutoMax operates in numerous taxing jurisdictions,
the application of tax laws can be subject to diverging and sometimes conflicting interpretations by tax authorities of these jurisdictions.
It is not uncommon for tax authorities in different countries to have conflicting views. In addition, tax laws are dynamic and subject
to change as new laws are passed and new interpretations of the law are issued or applied. For example, the work being carried out by
the OECD on base erosion and profit shifting as a response to increasing globalization of trade could result in changes in tax treaties
or the introduction of new legislation that could impose an additional tax on businesses. As a result of changes to laws or interpretations,
AutoMax&rsquo;s tax positions could be challenged, and its income tax expenses could increase in the future.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There can be no assurance
that its effective tax rate for the year ended December 31, 2023 will not change over time as a result <FONT STYLE="background-color: white">of
changes in corporate income tax rates or other changes in the tax laws of the jurisdictions in which AutoMax operates. Any changes in
tax laws could have an adverse impact on its financial results. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Environmental, social and corporate governance
(&ldquo;ESG&rdquo;) issues, including those related to climate change and sustainability, may have an adverse effect on our business,
financial condition and results of operations and damage AutoMax&rsquo;s reputation.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Public
companies are facing increasing scrutiny related to ESG practices and disclosures from certain investors, capital providers, shareholder
advocacy groups, other market participants, and other stakeholder groups. For example, certain institutional and individual investors
have requested various ESG-related information and disclosures as they increasingly incorporate ESG criteria in making investment and
voting decisions. With this increased focus, public reporting regarding ESG practices is becoming more broadly expected. Such increased
scrutiny may result in increased costs, enhanced compliance or disclosure obligations, or other adverse impacts on AutoMax&rsquo;s business,
financial condition or results of operations. If AutoMax&rsquo;s ESG practices and reporting do not meet investor or other stakeholder
expectations, which continue to evolve, AutoMax may be subject to investor or regulator engagement regarding such matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">In
March 2024, the SEC published climate disclosure rules, subject to which SciSparc, upon consummation of the Merger, would be required
to disclose certain climate-related information such as governance of climate-related risks and relevant risk management processes, among
other things. While the final rules have yet to be implemented and are subject to ongoing litigation, we and AutoMax cannot predict the
ultimate scope and impact these rules will have on AutoMax&rsquo;s business. If the SEC&rsquo;s climate disclosure rules are implemented,
they would likely result in additional legal, accounting and financial compliance and increased general and administrative expenses. Moreover,
this could result in increased management time and attention to ensure we are compliant with the regulations and expectations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to AutoMax&rsquo;s Financing
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax may not be able to satisfy its debt
obligations upon the occurrence of a change in control under its debt instruments. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">AutoMax
intends to continue making investments to support its business growth and will likely require additional funds to respond to business
challenges and opportunities, including the need to develop new features or enhance its technology and solutions, improve our operating
infrastructure to support volume growth or acquire complementary businesses and technologies. Accordingly, AutoMax may need to engage
in equity or debt financing to secure additional funds if its existing sources of cash and any funds generated from operations do not
provide it with sufficient capital. If AutoMax raises additional funds through future issuances of equity or convertible debt securities,
its existing stockholders could suffer significant dilution, and any new equity securities AutoMax issues could have rights, preferences,
and privileges superior to those of holders of its other classes of shares. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Any
future debt financing that AutoMax may secure in the future could involve restrictive covenants relating to its capital raising activities
and other financial and operational matters, which may make it more difficult for AutoMax to obtain additional capital and to pursue business
opportunities, including potential acquisitions. AutoMax may not be able to obtain additional financing on terms favorable to it, if at
all. If AutoMax is unable to obtain adequate financing or financing on terms satisfactory to it when it requires it, AutoMax&rsquo;s ability
to continue to support its business growth and to respond to business challenges and opportunities could be significantly impaired, and
its business may be adversely affected</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Increases in interest rate could materially
adversely affect AutoMax&rsquo;s business, financial condition, and results of operations. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">The
recent inflation, geopolitical issues, increase in energy costs, increases in interest rates, unstable global conditions and changes in
currency exchange rates have led to global economic instability. Furthermore, as interest rates are reaching historically high records,
it could impede AutoMax&rsquo;s ability to obtain financing or comply with its existing credit lines if the banks. Such changes, and their
impact on the global macro-economic environment, can impact AutoMax&rsquo;s business, operating results, and financial condition. Furthermore,
as the majority of AutoMax&rsquo;s customers rely on credit financing to purchase vehicles, such increases to interest rates could make
it less appealing and/or more difficult to purchase vehicles and thus decrease AutoMax&rsquo;s sales, which could adversely affect AutoMax&rsquo;s
business, financial condition and results of operations.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax may experience credit default or
losses if our customers default from the financing it provides.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">As
for the date of the report, through certain subsidiaries, AutoMax provides its customers with credit lines in low volumes. However, as
is customary in the automotive industry, it is possible that according to AutoMax&rsquo;s management decision, sales made to its customers
will be partially made on credit. In such cases, AutoMax may be exposed to the risk that its customers will not meet their obligations
to repay the full amount of the loan made available to them for the purpose of purchasing the vehicles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>New laws, regulations,
or governmental policies in response to climate change, including fuel economy and greenhouse gas emission standards, or changes to existing
standards, could adversely impact AutoMax&rsquo;s business, results of operations, financial condition, cash flow, and prospects. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">AutoMax
is subject to a variety of local laws and regulations that pertain to the environment. Its business involves the use, handling and disposal
of hazardous materials and wastes, including motor oil, gasoline, solvents, lubricants, paints and substances. AutoMax is subject to compliance
with regulations concerning, among other things, the operation of underground and above-ground gasoline storage tanks, gasoline dispensing
equipment, above-ground oil tanks and automotive paint booths. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">The
Clean Air Law, 5768-2008 (the &ldquo;Clean Air Law&rdquo;) authorizes the Israeli Minister of Environmental Protection (the &ldquo;Minister&rdquo;)
to set provisions regarding the prevention and reduction of air pollution from mobile emission sources, in accordance with values commonly
accepted in the developed countries of the world. The Clean Air Law determines that a person shall not sell, import or market a mobile
emission source, except in accordance with the provisions set by the Minister. This law also states that it is mandatory to include the
degree of air pollution of the vehicle and data regarding the fuel consumption of the vehicle in any new vehicle&rsquo; advertisement,
as part of the advertisement itself; and, in addition, said data must be displayed by any entity engaged in the business of selling and
marketing new vehicles within its premises. Similar provisions were established as part of the Clean Air Regulations (disclosure of air
pollution data from a motor vehicle in an advertisement), 5769-2009, as well. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">To
the best of AutoMax&rsquo;s understanding, it complies with the provisions of the Clean Air Law and the regulations established by virtue
thereof and include the required data in its publications. In addition, the Clean Air Regulations (air pollution from vehicles), 5772-2012
determines what constitutes unreasonable air pollution from a vehicle and regulates the obligation to carry out an air pollution test
for a vehicle before registering it, issuing a license, and renewing it. It should be noted that new vehicles imported to Israel undergo
inspections to verify their suitability for delivery and registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">In
addition, there is a noticeable increase in the cooperative economy trend and a trend of decreasing the environmental damages caused by
the use of vehicles, which are expressed, inter alia, by increase in demand for the use of electric and hybrid vehicles, by the development
of new models of vehicle&rsquo; sharing, by short-term vehicle rentals, in a pay-as-you-go model, and by shared travels. Alongside this,
major cities in Europe are promoting processes intended to reduce and even limit completely the entrance of polluting vehicles into the
cities. This trend has recently expanded to Israel, as part of which, restrictions were imposed on the entry of polluting vehicles into
Jerusalem and Haifa, and similar restrictions are expected to enter into force in Tel Aviv as well. The developments described above may
create uncertainty in the long term regarding the motorization level as well as the growth rate of the vehicles&rsquo; manufacturing industry
in which manufacturers whose vehicles we import are operating, as well as reducing, in the long term, the demand for car ownership, and
thus influence AutoMax&rsquo;s activity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to AutoMax&rsquo;s Cybersecurity
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to maintain the security and functionality
of AutoMax&rsquo;s information systems, or to defend against or otherwise prevent a cybersecurity attack or data breach, could adversely
affect its business, financial position, results of operations and liquidity.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">AutoMax&rsquo;s
activities are linked by information systems, including telecommunications, the internet, network communications, emails and various computer
hardware and software applications. As such, it could suffer damage to the aforementioned communication systems. In the current environment,
there are numerous and evolving risks with regards to cybersecurity and privacy, including criminal hackers, hacktivists, state-sponsored
intrusions, industrial espionage, employee malfeasance and human or technological error.&nbsp;While AutoMax implements various measures
to minimize and even prevent these risks, including having a detailed action policy, it cannot guarantee no cyber-attack may be carried
out. Computer hackers and others routinely attempt to breach the security of technology products, services and systems, and to fraudulently
induce employees, customers, sub-contractors, agents, distributors or others to disclose information or unwittingly provide access to
systems or data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Although
AutoMax has invested in measures to reduce these risks, it can provide no assurance that its current IT systems are fully protected against
third-party intrusions, viruses, hacker attacks, information or data theft or other similar threats. The cost and operational consequences
of implementing, maintaining and enhancing further data or system protection measures could increase significantly to overcome increasingly
intense, complex, and sophisticated global cyber threats. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Despite
its best efforts, AutoMax is not fully insulated from data breaches and system disruptions and, accordingly, it has experienced and expects
to continue to experience actual or attempted cyberattacks of its IT networks. To the best of AutoMax&rsquo;s knowledge, no cybersecurity
incidents were detected. Although no attempted cyberattacks has had a material adverse effect on its operations or financial condition
thus far, AutoMax cannot guarantee that any such incidents will not have a material adverse effect on our operations or financial condition
in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">As
such, its tools and servers are vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering with the
AutoMax computer systems and tools located at its facility, at cloud services or at customer sites, or could be subject to system failures
or malfunctions for other reasons. Increased information technology security threats and more sophisticated computer crime pose a risk
to the security of our systems and networks and the confidentiality, availability and integrity of our data or customer data. Cybersecurity
attacks could also include attacks targeting the security, integrity and/or reliability of the hardware and software installed in its
products. System failures or malfunctioning could disrupt AutoMax&rsquo;s operations and its ability to timely and accurately process
and report key components of its financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>AutoMax&rsquo;s collection, use, storage,
disclosure, transfer and other processing of personal information, could give rise to significant costs, liabilities and other risks,
including as a result of investigations, inquiries, litigation, fines, legislative and regulatory action and negative press about its
privacy and data protection practices, which may harm our business, financial conditions, results of operations and prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">AutoMax&rsquo;s
operations are dependent on secure processing, transmission, storing on its computers and networks proprietary and confidential information.
AutoMax uses various third-party storage platforms which could make it more vulnerable to such cyberattacks. Furthermore, AutoMax relies
on digital technologies to process payments, both on its networks and third-party systems. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Privacy
laws are ever changing and continue to create new individual privacy rights, including regulations regarding the manner in which such
personal information should be handled. As part of its ongoing operations, AutoMax gathers certain personal information from customers,
vendors, manufactures and others. AutoMax has invested in implementing security controls and adapting its systems, amongst others, by
engaging Integrity Consulting and Risk Management (I.C.M.) Ltd., which manages information security and privacy protection within the
company. However, any misuse of such information or storing it inappropriately and not adequately protecting it could lead to inquiries,
litigation, fines, legislative and regulatory action against AutoMax. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">In
light of the stated, there is a certain dependence on the information security, backup and retrieval capabilities of those providers.
In this aspect, AutoMax has a system of backups, designed to create a recovery mechanism from a situation where one backup environment
cannot, for whatever reason, support the provision of services. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>AutoMax&rsquo;s General Risk Factors </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Macroeconomic factors such as fluctuation
in vehicle prices, fuel prices, supply chain disruptions, and vehicle-related technology advancements could have an adverse effect on
AutoMax&rsquo;s revenues and operating results. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">Macroeconomic
factors that affect oil prices and the automobile and commodity markets can have adverse effects on AutoMax&rsquo;s revenues, revenue
growth rates (if any), and operating results. Significant increases in the cost of fuel could lead to a reduction in miles driven per
car and a reduction in accident rates. A material reduction in accident rates, whether due to, among other things, a reduction in miles
driven per car, vehicle-related technological advances such as accident avoidance systems and, to the extent widely adopted, the advent
of autonomous vehicles, could have a material impact on revenue growth. Similarly, a reduction in total loss frequency rates, due to among
other things, sharp increases in used car prices that make it less economical for insurance company sellers to declare a vehicle involved
in an accident a total loss, could also have a material impact on revenue growth. In addition, under the AutoMax Percentage Incentive
Program contracts (&ldquo;<B>PIP</B>&rdquo;), the cost of transporting the vehicle to one of our facilities is included in the PIP fee.
AutoMax may incur increased fees, which it may not be able to pass on to its vehicle sellers. A material increase in transportation rates
could have a material impact on AutoMax&rsquo;s operating results. Volatility in fuel, commodity, and used car prices could have a material
adverse effect on its revenues and revenue growth rates in future periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exchange rate fluctuations between the U.S,
dollar, Euro and the New Israeli Shekel currencies may negatively affect AutoMax&rsquo;s earnings. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of the international
nature of AutoMax&rsquo;s business, it is exposed to risks associated with changes in foreign currency exchange rates. Substantially all
its cost of purchases are either in U.S. dollars or Euros while the majority of its revenues and AutoMax&rsquo;s management, marketing,
sales and research and development costs are in NIS. AutoMax is therefore exposed to foreign currency risk due to fluctuations in exchange
rates. This may result in gains or losses with respect to movements in exchange rates, which may be significant and may also cause fluctuations
in reported financial information that are not necessarily related to its operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to AutoMax&rsquo;s Operations
in Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Conditions in Israel, including the ongoing
war between Israel and Hamas, and other conflicts in the region, may adversely affect AutoMax&rsquo;s operations and limit its ability
to market its products, which would lead to a decrease in revenues.</I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AutoMax is incorporated under
the laws of the State of Israel, and its employees, including management members, operate from their offices that are located in Tel Aviv,
Israel. In addition, a number its officers and directors are residents of Israel. Accordingly, AutoMax&rsquo;s business and operations
are directly affected by economic, political, geopolitical and military conditions in Israel. Since the establishment of the State of
Israel in 1948, a number of armed conflicts have occurred between Israel and its neighboring countries and terrorist organizations active
in the region. These conflicts have involved missile strikes, hostile infiltrations and terrorism against civilian targets in various
parts of Israel, which have negatively affected business conditions in Israel.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2023, Hamas terrorists
infiltrated Israel&rsquo;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas
also launched extensive rocket attacks on Israeli population and industrial centers located along Israel&rsquo;s border with the Gaza
Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians
and soldiers. Following the attack, Israel&rsquo;s security cabinet declared war against Hamas and a military campaign against these terrorist
organizations commenced in parallel to their continued rocket and terror attacks.&nbsp;As a result of the war, operations at two of AutoMax&rsquo;s
branch locations were closed and have not reopened as of the date of this prospectus.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The intensity and duration
of Israel&rsquo;s current war against Hamas is difficult to predict, as are such war&rsquo;s economic implications on our business and
operations and on Israel&rsquo;s economy in general. These events may be intertwined with wider macroeconomic indications of a deterioration
of Israel&rsquo;s economic standing, for instance, a downgrade in Israel&rsquo;s credit rating by rating agencies (such as the recent
downgrade by Moody&rsquo;s of its credit rating of Israel from A1 to A2, as well as the downgrade of its outlook rating from &ldquo;stable&rdquo;
to &ldquo;negative&rdquo; and the S&amp;P Global lowered its long-term credit rating from AA- to A+, as well as a downgrade of its short-term
credit ratings from A-1+ to A-1, with an outlook on the long-term ratings &ldquo;negative&rdquo;). which may have a material adverse effect
on AutoMax and its ability to effectively conduct its operations.&nbsp;As many of AutoMax&rsquo;s customers purchase their vehicles through
credit financing, an adverse material effect on Israel&rsquo;s economy could impact the ability to obtain such credit financing on favorable
terms, which in turn could lead to a decrease in AutoMax sales.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Israeli
security cabinet&rsquo;s declaration of war against Hamas and possible hostilities with other organizations, several hundred thousand
Israeli military reservists were drafted to perform immediate military service. Certain of AutoMax&rsquo;s employees and consultants in
Israel, in addition to employees of our service providers located in Israel, have been called, and additional employees may be called,
for service in the current or future wars or other armed conflicts with Hamas and others, and such persons may be absent for an extended
period of time. As a result, its operations may be disrupted by such absences, which disruption may materially and adversely affect its
business and results of operations. Additionally, the absence of employees of AutoMax&rsquo;s Israeli suppliers and contract manufacturers
due to their military service in the current or future wars or other armed conflicts may disrupt their operations, which in turn may materially
and adversely affect its ability to deliver or provide products and services to customers.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Following the attack by Hamas
on Israel&rsquo;s southern border, Hezbollah in Lebanon also launched missile, rocket, drone and shooting attacks against Israeli military
sites, troops and Israeli towns in northern Israel. In response to these attacked, the Israeli army has carried out a number of targeted
strikes on sites belonging to Hezbollah in Lebanon. Recently, Iran has directly joined the hostilities against Israel by firing hundreds
of drones, ballistic missiles and guided missiles to Israel causing further uncertainty in the region. While currently no damages were
registered in Israel from such attack, the situation is developing and could lead to additional wars and hostilities in the Middle East.
It is possible that other terrorist organizations, including Palestinian military organizations in the West Bank will join the hostilities.
Such hostilities may include terror and missile attacks. In the event that AutoMax&rsquo;s facilities are damaged as a result of hostile
actions, or hostilities otherwise disrupt its ongoing operations, its ability to deliver or provide products and services in a timely
manner to meet AutoMax&rsquo;s contractual obligations towards customers and vendors could be materially and adversely affected. AutoMax&rsquo;s
commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli
government currently covers the reinstatement value of certain direct damages that are caused by terrorist attacks or acts of war, AutoMax
cannot assure you that such government coverage will be maintained or that it will sufficiently cover its potential damages. Any losses
or damages incurred by AutoMax could have a material adverse effect on its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Provisions of Israeli law may make it easy
for AutoMax&rsquo;s shareholders to demand that AutoMax convenes a shareholders meeting, and/or allow shareholders to convene a shareholder
meeting without the consent of AutoMax&rsquo;s management, which may disrupt AutoMax&rsquo;s management&rsquo;s ability to run the company.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Israeli law may allow any
one or more of AutoMax&rsquo;s shareholders holding, in the aggregate, at least 5% of our voting rights to demand that we convene a special
shareholders meeting. Also, in the event that AutoMax chooses not to convene a special shareholders meeting pursuant to such a request,
Sections 64-65 of the Companies Law provide, among others, that such shareholders may independently convene a special shareholders meeting
within three months (or under court&rsquo;s ruling) and require AutoMax to cover the costs, within reason, and as a result thereof, AutoMax&rsquo;s
directors might be required to repay such costs. If AutoMax&rsquo;s shareholders decide to exercise these rights in a way inconsistent
with AutoMax&rsquo;s management&rsquo;s strategic plans, AutoMax&rsquo;s management&rsquo;s ability to run the company may be disrupted,
and this process may entail significant costs to the company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_004"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of the statements made
under &ldquo;Prospectus Summary,&rdquo; &ldquo;Risk Factors,&rdquo; &ldquo;Use of Proceeds,&rdquo; and elsewhere in this prospectus, including
in our 2023 Annual Report, incorporated by reference herein, and other information included or incorporated by reference in this prospectus,
constitute forward-looking statements. Forward-looking statements are often characterized by the use of forward-looking terminology such
as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo;
&ldquo;believe,&rdquo; &ldquo;should,&rdquo; &ldquo;intend,&rdquo; &ldquo;project&rdquo; or other similar words, but are not the only
way these statements are identified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">These
forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, statements
that contain projections of results of operations or of financial condition, expected capital needs and expenses, statements relating
to the research, development, completion and use of our product candidates, and all statements (other than statements of historical facts)
that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements
on assumptions and assessments made by our management in light of their experience and their perception of historical trends, current
conditions, expected future developments and other factors they believe to be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Important
factors that could cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking
statements include, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to raise capital through the issuance of additional securities and ability to continue as a going concern;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our ability to advance the development our pharmaceutical product candidates, including the anticipated starting and ending dates of our anticipated clinical trials</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our assessment of the potential of our pharmaceutical product candidates to treat certain indications</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our ability to successfully receive approvals from the FDA, or other regulatory bodies, including approval to conduct clinical trials, the scope of those trials and the prospects for regulatory approval of, or other regulatory action with respect to our product candidates, including the regulatory pathway to be designated to our product candidates</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">the regulatory environment and changes in the health policies and regimes in the countries in which we operate, including the impact of any changes in regulation and legislation that could affect the pharmaceutical industry</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our ability to commercialize our existing product candidates and future sales of our existing product candidates or any other future potential product candidates</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our ability to meet our expectations regarding the commercial supply of our product candidates</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">our ability to integrate our new eCommerce operations business, which focuses on the sale of hemp-based products on the Amazon.com marketplace</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to pursue a restructuring plan which involves transferring our pharmaceutical activities to a new wholly-owned subsidiary and listing it on a leading stock exchange;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">the overall global economic environment</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general market, political and economic conditions in the countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the recent attack by Hamas and other terrorist organizations from the Gaza Strip and Israel&rsquo;s war against them and hostilities with Hezbollah on the northern border of Israel;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected capital expenditures and liquidity;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our strategy;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">those factors discussed in the section &ldquo;Risk Factors&rdquo; beginning on page 4 of this prospectus.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">These
statements are only current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our
or our industry&rsquo;s actual results, levels of activity, performance or achievements to be materially different from those anticipated
by the forward-looking statements. We discuss many of these risks in &ldquo;Item 3. &mdash; Key Information &mdash; D. Risk Factors&rdquo;
in our Annual Report and in this prospectus in greater detail under the heading &ldquo;Risk Factors&rdquo; on page 4 of the prospectus.
You should not rely upon forward-looking statements as predictions of future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking
statements, whether as a result of new information, future events or otherwise, after the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_005"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
our Ordinary Shares that may be offered and sold from time to time by YA, the Selling Shareholder. All of the Ordinary Shares offered
by the Selling Shareholder pursuant to this prospectus will be sold by the Selling Shareholder for its own account. We will not receive
any of the proceeds from these sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may receive up to $20.0&nbsp;million
aggregate gross proceeds under the SEPA from any sales we make to YA pursuant to the SEPA. To date, we have not sold any Ordinary Shares
(other than the Commitment Shares), pursuant to the SEPA. However, we are unable to estimate the actual amount of proceeds that we may
receive, as it will depend on the number of shares that we choose to sell, our ability to meet the conditions to purchases set forth in
SEPA, market conditions and the price of our Ordinary Shares, among other factors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to use any proceeds
that we receive under the SEPA for working capital, which includes research and development to advance our technology, general corporate
purposes, and pursuing strategic opportunities which include expanding our pipeline and investments in other companies that may not necessarily
be aligned with our current business strategy. We cannot provide any assurance that we will be able to carry out any potential investments
we may identify. As of the date of this prospectus, we cannot specify with certainty all of the particular uses, and the respective amounts
we may allocate to those uses, for any net proceeds we receive. Accordingly, we will retain broad discretion over the use of these proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_006"></A>CAPITALIZATION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth our cash and cash
equivalents and our capitalization as of December 31, 2023:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma basis to give effect to (i) our extension of a $1.4 million bridge loan to a leading vehicle importer company in Israel; (ii) the issuance of 55,293 Commitment Shares to YA; (iii) the issuance of 925,159 ordinary shares sold under the SEPA; and (iv) the exercises of 1,587,716 pre-funded warrants and issuance of 1,587,716 Ordinary Shares.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a pro forma as adjusted basis to give effect to bridge loan and issuances described above and the additional issuance of 4,422,435&nbsp;Ordinary Shares under the SEPA, at an assumed public offering price of $3.74&nbsp;per Ordinary Share, which is the last reported sales price on Nasdaq of our Ordinary Shares on February 26, 2024, and after deducting estimated offering expenses, as if the sale of the Ordinary Shares had occurred on December 31, 2023.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this table
should be read in conjunction with and is qualified by reference to the financial information thereto and other financial information
incorporated by reference into this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31, 2023<BR> (U.S. dollars in thousands)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Pro Forma</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Adjusted</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,076</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,300</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">20,578</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,182</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">13,806</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,084</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,595</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,595</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,595</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shareholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Share capital and premium</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">67,150</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">84,428</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ordinary Shares, no par value: 706,683 Ordinary Shares issued and outstanding (actual); 3,097,815 Ordinary Shares issued and outstanding (Pro Forma); and 7,372,751 Ordinary Shares issued and outstanding (as adjusted)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Reserve for share-based payment transactions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,282</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,282</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,282</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,190</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,190</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation reserve</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">497</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">497</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">497</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Transactions with non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">810</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">810</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">810</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Accumulated loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(68,621</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(68,621</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(68,621</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Non-controlling interests</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,973</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,973</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,973</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,587</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,211</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">29,489</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table above is based on
706,683 Ordinary Shares outstanding as of December 31, 2023. This number excludes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,013 Ordinary Shares issuable upon the exercise of options outstanding under our 2015 Share Option Plan, at a weighted average exercise price of $166.28 per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,013,787 Ordinary Shares reserved for issuance and available for future grant under our 2023 Share Option Plan;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,694 Ordinary Shares issuable upon the exercise of outstanding warrants, with exercise prices ranging from $68.38 to $637.0 per Ordinary Share; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,285,000 Ordinary Shares issuable upon the exercise of outstanding pre-funded warrants, with exercise prices ranging from $0.001 to $0.026 per Ordinary Share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_007"></A>SELLING SHAREHOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">This
prospectus relates to the possible resale from time to time by YA of any or all of the Ordinary Shares that have been or may be issued
by us to YA under the SEPA. For additional information regarding the issuance of Ordinary Shares covered by this prospectus, see the section
titled &ldquo;<I>Prospectus Summary &mdash;Standby Equity Purchase Agreement with YA</I>&rdquo; above. Except for the transactions contemplated
by the SEPA, YA does not, and has not had, any material relationship with us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;The
table below presents information regarding the Selling Shareholder and the Ordinary Shares that it may offer from time to time under this
prospectus. This table is prepared based on information supplied to us by the Selling Shareholder. The number of shares in the column
&ldquo;Maximum Number of Ordinary Shares to be Offered Pursuant to this Prospectus&rdquo; represents all of the Ordinary Shares that the
Selling Shareholder may offer under this prospectus. The Selling Shareholder may sell some, all or none of its shares in this offering.
We do not know how long the Selling Shareholder will hold the shares before selling them, and we currently have no agreements, arrangements
or understandings with the Selling Shareholder regarding the sale of any of the shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Beneficial
ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes Ordinary Shares with
respect to which the Selling Shareholder has voting and investment power. The percentage of Ordinary Shares beneficially owned by the
Selling Shareholder prior to the offering shown in the table below is based on an aggregate of 3,097,815 of our Ordinary Shares outstanding
on April 30, 2024. The number of shares that may actually be sold by us under the SEPA may be fewer than the number of shares being offered
by this prospectus. The fourth column assumes the sale of all of the shares offered by the Selling Shareholder pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Shares of<BR> Ordinary Shares Owned<BR> Prior to Offering</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Maximum Number of <BR> Ordinary Shares to be<BR> Offered Pursuant<BR> to this Prospectus</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Ordinary<BR> Shares Owned After<BR> Offering</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><B>Name of Selling Shareholder</B></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number<SUP>(1)</SUP></B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number<SUP>(2)</SUP></B></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">YA II PN, LTD.(3) (4)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4,422,435</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have excluded from the number of shares beneficially owned prior to the offering all of the shares that YA may be required to purchase under the SEPA, because the issuance of such shares is solely at our discretion and is subject to conditions contained in the SEPA, the satisfaction of which are entirely outside of YA&rsquo;s control, including the registration statement that includes this prospectus becoming and remaining effective.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumes the sale of all shares being offered pursuant to this prospectus. Depending on the price per share at which we sell our Ordinary Shares to YA pursuant to the SEPA, we may need to sell to YA under the SEPA more shares of our Ordinary Shares than are offered under this prospectus in order to receive aggregate gross proceeds equal to the $20.0 million total commitment under the SEPA. If we choose to do so and otherwise satisfy the conditions in the SEPA, we must first register for resale under the Securities Act such additional shares. The number of shares ultimately offered for resale by YA is dependent upon the number of shares we sell to YA under the SEPA.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">YA is a fund managed by Yorkville Advisors Global, LP, or Yorkville LP. Yorkville Advisors Global II, LLC, or Yorkville LLC, is the General Partner of Yorkville LP. All investment decisions for YA are made by Yorkville LLC&rsquo;s President and Managing Member, Mr. Mark Angelo. The business address of YA is 1012 Springfield Avenue, Mountainside, NJ 07092.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the SEPA, YA is not permitted to purchase nor acquire Ordinary Shares of the Company under the SEPA that would result in it beneficially owning in excess of 9.99% of the outstanding voting power or number of Ordinary Shares outstanding.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_008"></A>DESCRIPTION OF SHARE CAPITAL</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
following description of our share capital and provisions of the amended and restated articles of association (the &ldquo;Articles&rdquo;)
are summaries and do not purport to be complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Registration number and purposes of the
Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
registration number with the Israeli Registrar of Companies is 51-358165-2. Our purpose as set forth in our Articles is to engage in any
lawful activity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Type and class of
securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
authorized share capital consists of 75,000,000 Ordinary shares. All of our outstanding Ordinary Shares have been validly issued, are
fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Preemptive rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
Ordinary Shares are not redeemable and are not subject to any preemptive right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Transfer of shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
fully paid Ordinary Shares are issued in registered form and may be freely transferred under our Articles, unless the transfer is restricted
or prohibited by another instrument, applicable law or the rules of a stock exchange on which the shares are listed for trade. The ownership
or voting of our Ordinary Shares by non-residents of Israel is not restricted in any way by our Articles or the laws of the State of Israel,
except for ownership by nationals of certain countries that are, or have been, in a state of war with Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Liability to further capital calls</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Our
board of directors may make, from time to time, such calls as it may deem fit upon shareholders with respect to any sum unpaid with respect
to shares held by such shareholders which is not payable at a fixed time. Such shareholder has to pay the amount of every call so made
upon him or her.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Election of directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
our Articles, our board of directors must consist of at least three (3) and not more than eight (8) directors, including, if applicable,
two external directors appointed as required under the Companies Law 5759-1999 (the &ldquo;Companies Law&rdquo;). Other than our external
directors (if any), our directors are divided into three classes with staggered three-year terms. Each class of directors consists, as
nearly as possible, of one third of the total number of directors constituting the entire board of directors. At each annual general meeting
of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors of that
class of directors is for a term of office that expires on the third annual general meeting following such election or re-election, such
that from 2020 and after, at each annual general meeting the term of office only one class of directors will expire. Each director, holds
office until the annual general meeting of our shareholders for the year in which his or her term expires and until his or her successor
is duly appointed, unless the tenure of such director expires earlier pursuant to the Companies Law upon the occurrence of certain events
or unless removed from office by a vote of the holders of at least 65% of the total voting power of our shareholders at a general meeting
of our shareholders in accordance with our amended and restated Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Further,&nbsp;our&nbsp;shareholders&nbsp;approved
an approval mechanism similar to a mechanism that exists in the Delaware Generate Corporate Law, which requires an affirmative vote of
the board of directors (by 75% of the members) in addition to the approval of our shareholders in order to amend such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
addition, if a director&rsquo;s office becomes vacant, the remaining serving directors may continue to act in any manner, provided that
the number of the serving directors shall not be less than three (3). If the number of serving Directors is lower than their minimal one,
the Board shall not be permitted to act, other than for the purpose of convening a general meeting of the Company&rsquo;s shareholders
for the purpose of appointing additional Directors. For further information on the election and removal of directors see &ldquo;Item 6.
Directors, Senior Management and Employees&mdash;C. Board Practices&rdquo; of the Company&rsquo;s Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Contested election</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Under our Articles, in
the event of a contested election, our board of directors in its discretion, will set the method of calculation of the votes and the manner
in which the resolutions will be presented to our shareholders at the general meeting. In the event that our board of directors does not
or is unable to make a determination on such matter, then the directors will be elected by a plurality of the voting power represented
at the general meeting in person or by proxy and voting on the election of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>Dividend and liquidation rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
may declare a dividend to be paid to the holders of our Ordinary Shares in proportion to their respective shareholdings. Under the Companies
Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company
unless the Company&rsquo;s articles of association provide otherwise. Our Articles do not require shareholder approval of a dividend distribution
and provide that dividend distributions may be determined by our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Pursuant
to the Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two
years, according to our then last reviewed or audited consolidated financial statements, provided that the date of the financial statements
is not more than six months prior to the date of the distribution, or we may distribute dividends that do not meet such criteria only
with court approval. In each case, we are only permitted to distribute a dividend if our board of directors and the court, if applicable,
determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable
obligations as they become due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to the holders of our Ordinary
Shares in proportion to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential
dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>Exchange controls</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">There
are currently no Israeli currency control restrictions on remittances of dividends on our Ordinary Shares, proceeds from the sale of the
shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of certain countries that are,
or have been, in a state of war with Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF RIGHTS TO PURCHASE THE ORDINARY
SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Rights and Rights Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors authorized,
pursuant to the Rights Plan, (i) the issuance, on December 8, 2023, of one special purchase right , or a &ldquo;Right for each Ordinary
Share outstanding at the Close of Business on December 8, 2023, or the &ldquo;Record Date, as well as (ii) the issuance of one Right for
each Ordinary Share issued after the Record Date and prior to the earliest of the Issuance Date, the Redemption Date (as defined below)
and the Final Expiration Date (as defined below) (including Ordinary Shares issued pursuant to the exercise, conversion or settlement
of securities exercisable for, convertible into or that may be settled for, Ordinary Shares or rights, in each case, issued or granted
prior to, and outstanding as of, the Issuance Date). Each Right will represent the right to purchase one (1) Ordinary Share, at the price
of $0.001 per share upon the terms and subject to the conditions described below.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights were issued pursuant
to a Rights Agreement, dated as of November 28, 2023, or the Rights Agreement, between the Company and Vstock Transfer LLC, as rights
agent, or the &ldquo;Rights Agent. Each Right will allow its holder to purchase from the Company one (1) Ordinary Share, at a purchase
price of $0.001 per Ordinary Share, once the Rights become exercisable. Prior to exercise, each Right does not give its holder any dividend,
voting, liquidation or other rights as a shareholder of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Exercise Period; Rights Certificates</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Rights will not be exercisable
until the close of business on the tenth (10<SUP>th</SUP>) day after the public announcement or public disclosure that a person or group
has become an &ldquo;Acquiring Person&rdquo; by obtaining beneficial ownership of 10% or more of the Company&rsquo;s outstanding Ordinary
Shares (subject to the parameters and exceptions described below and in the Rights Agreement, referred here as an &ldquo;Acquiring Person&rdquo;),
except if such person or group has become an Acquiring Person pursuant to an offer approved by the majority of the board of directors
(such date, upon which the Rights become exercisable, is referred to as the &ldquo;Issuance Date&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a Person&rsquo;s beneficial
ownership of the then-outstanding Ordinary Shares as of the time of the public announcement of the Rights Plan is at or above 10% (including
through entry into certain derivative positions), that person or group&rsquo;s then-existing ownership percentage would be grandfathered
and would not trigger the exercisability of the Rights, as that Person will not be deemed to be an Acquiring Person. However, the Rights
would become exercisable (and such Person will be deemed to be an Acquiring Person) if at any time after such announcement, that shareholder
increases its beneficial ownership percentage of Ordinary Shares of the Company by 0.5% or if at any time after such announcement, such
shareholder&rsquo;s beneficial ownership of Ordinary Shares is reduced to an amount that is less than 10% of the then-outstanding Ordinary
Shares and thereafter such shareholder becomes an Acquiring Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Until the Issuance Date, the
balances in the book-entry accounting system of the transfer agent for our Ordinary Shares or, in the case of certificated shares, Ordinary
Shares certificates, will also evidence the Rights, and any transfer of Ordinary Shares or, in the case of certificated shares, certificates
for Ordinary Shares, will constitute a transfer of Rights. After that date, the Rights will separate from the Ordinary Shares and be evidenced
solely by Rights Certificates that we will mail to all eligible holders of Ordinary Shares, or we may choose to use book-entry in lieu
of physical certificates. Under certain circumstances, any Rights held by an Acquiring Person or any Associate or Affiliate thereof are
void and may not be exercised. The Rights shall not be exercisable, and shall be void so long as held, by a holder in any jurisdiction
where the requisite qualification for the issuance to such holder, or the exercise by such holder of the Rights in such jurisdiction,
shall not have been obtained or be obtainable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in connection
with the issuance or sale of Ordinary Shares following the Issuance Date and prior to the redemption, exchange, or expiration of the Rights,
the Company (a) shall, with respect to Ordinary Shares so issued or sold pursuant to the exercise of share options or pursuant to any
other award or right under any employee benefit plan or arrangement, granted or awarded as of the Issuance Date (including, for example,
upon the or purchase of Ordinary Shares under the Company&rsquo;s share incentive plans), or upon the exercise, conversion or exchange
of securities hereinafter issued by the Company (except as may otherwise be provided in the instrument(s) governing such securities),
and (b) may, in any other case, if deemed necessary or appropriate by the board of directors, issue Rights Certificates representing the
appropriate number of Rights in connection with such issuance or sale; provided, however, that (i) no such Rights Certificate shall be
issued if, and to the extent that, the Company shall be advised by counsel that such issuance would create a significant risk of material
adverse tax consequences to the Company or the Person to whom such Rights Certificate would be issued, and (ii) no such Rights Certificate
shall be issued if, and to the extent that, appropriate adjustment shall otherwise have been made in lieu of the issuance thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Flip-In/Flip-Over</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a person or group becomes
an Acquiring Person, then beginning on the Issuance Date, all holders of Rights except the Acquiring Person or any associate or affiliate
thereof may, for a purchase price of $0.001 per one Ordinary Share, purchase one (1) Ordinary Share for each Ordinary Share of the Company
then beneficially owned by such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our Company is later acquired
in a merger or similar transaction after the Issuance Date, all holders of Rights except the Acquiring Person or any associate or affiliate
thereof may, for a purchase price of $0.001 per share (subject to adjustments as provided in the Rights Agreement, purchase one (1) times
the number of shares of the acquiring corporation, that each shareholder of the Company is entitled for each Ordinary Share held.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Scope of &ldquo;Acquiring Person&rdquo; Definition</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An &ldquo;Acquiring Person&rdquo;
is any Person who or which, together with all affiliates and associates of such Person, shall be the Beneficial Owner of 10% or more of
the Ordinary Shares of the Company then outstanding, but shall not include the Company, any Subsidiary of the Company, any employee benefit
or share ownership plan of the Company or any Subsidiary of the Company, or any entity holding Ordinary Shares for or pursuant to the
terms of any such plan. Notwithstanding the foregoing, no Person shall become an &ldquo;Acquiring Person&rdquo; as the result of an acquisition
of Ordinary Shares by the Company which, by reducing the number of Ordinary Shares of the Company outstanding, increases the proportionate
number of Ordinary Shares of the Company beneficially owned by such Person to 10% or more of the Ordinary Shares of the Company then outstanding;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that, if a Person shall become the Beneficial Owner of 10% or more of the Ordinary Shares of the Company then outstanding by reason of
share purchases by the Company and shall, after the public disclosure of such share purchases by the Company, become the Beneficial Owner
of any additional Ordinary Shares of the Company, then such Person shall be deemed to be an &ldquo;Acquiring Person.&rdquo; Notwithstanding
the foregoing, if the board of directors determines in good faith that a Person who would otherwise be an &ldquo;Acquiring Person&rdquo;
has become such inadvertently, and such Person divests or undertakes to divest, as promptly as practicable a sufficient number of Ordinary
Shares, so that such Person would no longer be an &ldquo;Acquiring Person,&rdquo; as defined pursuant to the foregoing provisions of this
paragraph, then such Person shall not be deemed to be an &ldquo;Acquiring Person&rdquo; for any purposes of the Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a bona fide swaps dealer
who would otherwise be an &ldquo;Acquiring Person&rdquo; has become so as a result of its actions in the ordinary course of its business
that the Board determines were taken without the intent or effect of evading or assisting any other Person to evade the purposes and intent
of the Rights Agreement, or otherwise seeking to control or influence the management or policies of the Company, then, and unless and
until the board of directors shall otherwise determine, such Person shall not be deemed to be an &ldquo;Acquiring Person&rdquo; for purposes
of the Rights Agreement. Furthermore, no Person who purchases securities of the Company either directly from the Company or from any underwriters
engaged by the Company, in each case in a securities offering transaction approved by the board of directors as an offering intended to
allow a Person or a group of Persons to beneficially own, upon the consummation of such offering, more than 10% of the Ordinary Shares
of the Company then outstanding, shall become an &ldquo;Acquiring Person&rdquo; unless such Person shall, after the consummation of such
offering, beneficially own additional Ordinary Shares of the Company in the amount equal to or greater than the sum of (I) the lowest
Ordinary Shares beneficially owned by such Person as a percentage of the outstanding Ordinary Shares as of immediately after the consummation
of such offering and (II) 0.5%. The definition of Acquiring Person is furthermore subject to the &ldquo;grandfathering&rdquo; scenarios
described under &ldquo;<I>Exercise Period; Rights Certificates</I>&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Exchange</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board may, at its option,
at any time after the Issuance Date, exchange all or part of the then outstanding and exercisable Rights (except for Rights that have
become void) for Ordinary Shares at an exchange ratio of one (1) Ordinary Share per Right, appropriately adjusted to reflect any adjustment
in the number of Rights, or the Exchange Ratio. However, the board of directors will not be empowered to effect such exchange at any time
after any Person (other than the Company, any Subsidiary of the Company, any employee benefit or share ownership plan of the Company or
any such Subsidiary, or any entity holding Ordinary Shares for or pursuant to the terms of any such plan), together with all affiliates
and associates of such Person, becomes the Beneficial Owner of 50% or more of the Ordinary Shares then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Immediately upon the action
of the board of directors ordering the foregoing exchange, the right to exercise the Rights that are to be exchanged will terminate and
the only right thereafter of a holder of such Rights shall be to receive that number of Ordinary Shares equal to the number of such Rights
held by such holder multiplied by the Exchange Ratio. In the event that there shall not be sufficient Ordinary Shares issued but not outstanding
or authorized but unissued to permit any exchange of Rights, the Company will take all such action as may be necessary to authorize additional
Ordinary Shares for issuance upon exchange of the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Anti-Dilution Provisions</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors may
adjust the purchase price of Ordinary Shares under each Right, the number of Ordinary Shares issuable under each Right, and the number
of outstanding Rights to prevent dilution that may occur from a share dividend, a share split, or a reclassification of the Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Amendments</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of the Rights Agreement
may be amended by our board of directors without the consent of the holders of the Rights. After a person or group becomes an Acquiring
Person, our board of directors may not amend the Rights Agreement in a way that adversely affects holders of the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Redemption</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors may
at its option, at any time prior to the Issuance Date, redeem all but not less than all the then outstanding Rights. The redemption of
the Rights by the board of directors may be made effective at such time, on such basis and with such conditions as the board of directors,
in its sole discretion, may establish (the effective date of redemption, the is referred to as the &ldquo;Redemption Date&rdquo;). Immediately
upon the effectiveness of the action of the board of directors ordering the redemption of the Rights, and without any further action and
without any notice, the right to exercise the Rights will terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Expiration</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Rights will expire on November 27, 2024, or
the Final Expiration Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp; <B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_009"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 21, 2024, we entered
into the SEPA with YA. The SEPA provides that, upon the terms and subject to the conditions set forth therein, YA is committed to purchase
up to $20.0&nbsp;million of our Ordinary Shares over an approximately 36-month commitment period. Of the Commitment Amount, to date we
have not sold any Ordinary Shares (other than the Commitment Shares). From time to time, and at our sole discretion, we may present YA
with advance notices to purchase our Ordinary Shares. The shares would be purchased pursuant to the SEPA at 97% of the market price, which
is defined as the lowest daily volume weighted average price of the Shares during the three consecutive trading days commencing on the
trading day immediately following our delivery of an advance notice to YA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Ordinary Shares offered
by this prospectus are being offered by the Selling Shareholder, YA. The Selling Shareholder is an &ldquo;underwriter&rdquo; within the
meaning of Section&nbsp;2(a)(11) of the Securities Act. We have agreed in the SEPA to provide customary indemnification to YA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is possible that our shares
may be sold from time to time by YA in one or more of the following manners:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary brokerage transactions and transactions in which the broker solicits purchasers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a block trade in which the broker or dealer so engaged will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to a broker-dealer as principal and resale by the broker-dealer for its account; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a combination of any such methods of sale.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YA has agreed that, during
the term of the SEPA, it shall not engage in any short sales or hedging transactions with respect to our Ordinary Shares, provided that
upon receipt of an advance notice, YA may sell shares that it is obligated to purchase under such advance notice prior to taking possession
of such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YA and any unaffiliated broker-dealer
will be subject to liability under the federal securities laws and must comply with the requirements of the Exchange Act, including without
limitation, Rule&nbsp;10b-5 and Regulation&nbsp;M under the Exchange Act. These rules and regulations may limit the timing of purchases
and sales of Ordinary Shares by YA or any unaffiliated broker-dealer. Under these rules and regulations, YA and any unaffiliated broker-dealer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may not engage in any stabilization activity in connection with our securities;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">must furnish each broker which offers shares of our common stock covered by the prospectus and accompanying prospectus that are a part of our Registration Statement with the number of copies of such prospectus and accompanying prospectus which are required by each broker; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may not bid for or purchase any of our securities or attempt to induce any person to purchase any of our securities other than as permitted under the Exchange Act.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These restrictions may affect
the marketability of the Ordinary Shares by YA and any unaffiliated broker-dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay the expenses incident
to the registration under the Securities Act of the offer and sale of the Ordinary Shares covered by this prospectus by the Selling Shareholder.
We estimate that our total expenses for the offering will be approximately $98,000.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_010"></A>EXPENSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Set forth below is an itemization of the total
expenses expected to be incurred by us in connection with the offer and sale of the securities.&nbsp;With the exception of the SEC registration
fee, all amounts are estimates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,854.93</TD><TD STYLE="padding-bottom: 3pt; width: 1%; text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Printer fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="padding-bottom: 3pt; text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">80,000</TD><TD STYLE="padding-bottom: 3pt; text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounting and professional fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,500</TD><TD STYLE="padding-bottom: 3pt; text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,500</TD><TD STYLE="padding-bottom: 3pt; text-align: left">*</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">97,854.93</TD><TD STYLE="padding-bottom: 3pt; text-align: left">*</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.5pt; text-indent: -20.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">*</TD><TD STYLE="text-align: justify">Previously paid.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_011"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal matters concerning
the SEPA will be passed upon for us by Sullivan &amp; Worcester LLP, New York, New York. Certain legal matters with respect to the validity
of the Ordinary Shares offered by this prospectus will be passed upon for us by Meitar | Law Offices, Ramat Gan, Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_012"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of SciSparc Ltd. appearing in SciSparc Ltd.&rsquo;s Annual Report (Form 20-F) for the year ended December 31, 2023, have been
audited by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, independent registered public accounting firm, as set
forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated
herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements of Automax Motors Ltd. as of December 31, 2023 and 2022 and the Years ended December 31, 2023 and 2022, incorporated by reference
in this prospectus have been audited by Ben David Shalvi Kop &amp; Co, independent registered public accounting firm, as set forth in
their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated
herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_013"></A>ENFORCEABILITY OF CIVIL LIABILITIES</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated under
the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in the registration
statements of which this prospectus forms a part, a substantial majority of whom reside outside of the United States, may be difficult
to obtain within the United States. Furthermore, because substantially all of our assets and a substantial of our directors and officers
are located outside of the United States, any judgment obtained in the United States against us or any of our directors and officers may
not be collectible within the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have been informed by our
legal counsel in Israel, Meitar | Law Offices, that it may be difficult to assert U.S. securities law claims in original actions instituted
in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws reasoning Israel is not the
most appropriate forum to bring such a claim. In Israeli courts, the content of applicable U.S. law must be proved as a fact which can
be a time-consuming and costly process and certain matters of procedure will also be governed by Israeli law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to specified time
limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is
non-appealable, including judgments based upon the civil liability provisions of the Securities Act and the Exchange Act and including
a monetary or compensatory judgment in a non-civil matter, provided that among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was rendered by a court which was, according to the laws of the state of the court, competent to render the judgment;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the obligation imposed by the judgment is enforceable according to the rules relating to the enforceability of judgments in Israel and the substance of the judgment is not contrary to public policy; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is executory in the state in which it was given.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even if these conditions are
met, an Israeli court will not declare a foreign civil judgment enforceable if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was obtained by fraud;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli court;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment was rendered by a court not competent to render it according to the laws of private international law as they apply in Israel;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the judgment is contradictory to another judgment that was given in the same matter between the same parties and that is still valid; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a foreign judgment is enforced
by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred
out of Israel. The usual practice in an action before an Israeli court to recover an amount in a non-Israeli currency is for the Israeli
court to issue a judgment for the equivalent amount in Israeli currency at the rate of exchange in force on the date of the judgment,
but the judgment debtor may make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated
in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the annual statutory rate set by Israeli
regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="pos_014"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have filed with the SEC
a registration statement on Form&nbsp;F-1 under the Securities Act relating to this offering of our Ordinary Shares. This prospectus does
not contain all of the information contained in the registration statement. The rules and regulations of the SEC allow us to omit certain
information from this prospectus that is included in the registration statement. Statements made in this prospectus concerning the contents
of any contract, agreement or other document are summaries of all material information about the documents summarized, but are not complete
descriptions of all terms of these documents. If we filed any of these documents as an exhibit to the registration statement, you may
read the document itself for a complete description of its terms. The SEC maintains an Internet website that contains reports and other
information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through
the SEC&rsquo;s website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the information
reporting requirements of the Exchange Act that are applicable to foreign private issuers, and under those requirements are filing reports
with the SEC. Those other reports or other information may be inspected without charge at the locations described above. As a foreign
private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our
officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section&nbsp;16
of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports and financial
statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However,
we are required to file with the SEC, within 120&nbsp;days after the end of each fiscal year, or such applicable time as required by the
SEC, an annual report on Form&nbsp;20-F containing financial statements audited by an independent registered public accounting firm, and
will submit to the SEC, on Form&nbsp;6-K, unaudited interim financial information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
maintain a corporate website at www.scisparc.com. Information contained on, or that can be accessed through, our website does not constitute
a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. We will post
on our website any materials required to be so posted on such website under applicable corporate or securities laws and regulations, including,
posting any XBRL interactive financial data required to be filed with the SEC and any notices of general meetings of our shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><A NAME="pos_015"></A>INCORPORATION OF CERTAIN
INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to incorporate
by reference information into this document. This means that we can disclose important information to you by referring you to another
document filed separately with the SEC. The information incorporated by reference is considered to be a part of this document, except
for any information superseded by information that is included directly in this prospectus or incorporated by reference subsequent to
the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We incorporate by reference
the following documents or information that we have filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Annual Report on Form 20-F for the year ended December 31, 2023, filed on <A HREF="http://www.sec.gov/ix?doc=/Archives/edgar/data/1611746/000121390024028859/ea0202882-20f_scisparc.htm">April 1, 2024</A> (File No. 001-38041), as amended by the Form 20-F/A filed with the SEC on <A HREF="https://www.sec.gov/Archives/edgar/data/1611746/000121390024038779/ea0205098-20fa1_scisparc.htm">May 2, 2024</A>; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our Reports of Foreign Private Issuer on Form 6-K filed on <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024032202/ea0203697-6k_scisparc.htm">April 11, 2024</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1611746/000121390024039103/ea0204209-6k_scisparc.htm">May 2, 2024</A>; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the description of our Ordinary Shares contained in our <A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390017002651/f8a12b1216_therapixbio.htm">Form 8-A</A> filed on March 21, 2017 (File No. 001-38041), including any amendments or reports filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide you without
charge, upon your written or oral request, a copy of any of the documents incorporated by reference in this prospectus, other than exhibits
to such documents which are not specifically incorporated by reference into such documents. Please direct your written or telephone requests
to us at: SciSparc Ltd., 20 Raul Wallenberg Street, Tower A, Tel Aviv 6971916, Israel, Tel: +972-(3) 610-3100.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Up to 4,422,435 Ordinary
Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SciSparc Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 6. Indemnification of Directors, Officers and Employees </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, a
company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office
holder in advance from liability to the Company, in whole or in part, for damages caused to the Company as a result of a breach of duty
of care but only if a provision authorizing such exculpation is included in its articles of association. Our Articles of Association contain
such a provision. An Israeli company may not exculpate a director from liability arising out of a prohibited dividend or distribution
to shareholders.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An Israeli company may indemnify
an office holder in respect of the following liabilities and expenses incurred for acts performed as an office holder, either in advance
of an event or following an event provided a provision authorizing such indemnification is contained in its articles of association:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&rsquo;s award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the Company&rsquo;s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned events and amount or criteria;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including legal fees, incurred by the office holder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability, such as a criminal penalty, was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and (b) in connection with a monetary sanction;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including legal fees, incurred by the office holder or imposed by a court (i) in proceedings instituted against him or her by the Company, on its behalf or by a third party, or (ii) in connection with criminal proceedings in which the office holder was acquitted, or (iii) as a result of a conviction for a crime that does not require proof of criminal intent; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such office holder, or certain compensation payments made to an injured party imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An Israeli company may insure
an office holder against the following liabilities incurred for acts performed as an office holder if and to the extent provided in the
Company&rsquo;s articles of association:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of the duty of loyalty to the Company, to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the Company;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of the duty of care to the Company or to a third party, including a breach arising out of the negligent conduct of the office holder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on the office holder in favor of a third party;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on the office holder in favor of a third party harmed by a breach in an administrative proceeding; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses, including reasonable litigation expenses and legal fees, incurred by the office holder as a result of an administrative proceeding instituted against him or her, pursuant to certain provisions of the Israeli Securities Law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An Israeli company may not
indemnify or insure an office holder against any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of the duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the Company;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an act or omission committed with intent to derive illegal personal benefit; or</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a fine, monetary sanction or forfeit levied against the office holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Israeli Companies
Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee, the board of directors
(and, with respect to directors and the chief executive officer, by the shareholders). However, under regulations promulgated under the
Companies Law, the insurance of office holders shall not require shareholder approval and may be approved by only the compensation committee,
if the engagement terms are determined in accordance with the Company&rsquo;s compensation policy and that policy was approved by the
shareholders by the same special majority required to approve a compensation policy, provided that the insurance policy is on market terms
and the insurance policy is not likely to materially impact the Company&rsquo;s profitability, assets or obligations.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Articles of Association
allow us to exculpate, indemnify and insure our office holders for any liability imposed on them as a consequence of an act (including
any omission) which was performed by virtue of being an office holder. Our office holders are currently covered by a directors and officers&rsquo;
liability insurance policy.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into agreements
with each of our directors and executive officers exculpating them in advance from liability to us for damages caused to us as a result
of a breach of duty of care, and undertaking to indemnify them. This exculpation and indemnification is limited both in terms of amount
and coverage and it covers certain amounts regarding administrative proceedings insurable or indemnifiable under the Companies Law and
our Articles of Association.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the opinion of the SEC,
however, indemnification of directors and office holders for liabilities arising under the Securities Act, is against public policy and
therefore unenforceable.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no pending litigation
or proceeding against any of our office holders as to which indemnification is being sought, nor are we aware of any pending or threatened
litigation that may result in claims for indemnification by any office holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 7. Recent Sales of Unregistered Securities </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Set forth below are the sales
of all securities by the Company since May 1, 2021, which were not registered under the Securities Act. The Company believes that each
of such issuances was exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act, Rule 701
and/or Regulation S under the Securities Act. The conversions described below were exempt from registration under Securities Act in reliance
on Section 3(a)(9) of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 1, 2022, in connection
with the 2022 Private Placement. In connection with the 2022 Private Placement, we issued 136,388 units and pre-funded units at a purchase
price of $73.32 per unit (or $0.026 less per pre-funded unit) to an institutional investor. Each unit and pre-funded unit consisted of
one Ordinary Share (or Ordinary Share equivalent) and two non-tradable warrants each exercisable for one Ordinary Share for $66.82 (for
a total of 272,777 shares underlying the warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 30, 2022, we and the
institutional investor entered into a letter agreement and agreed, among other things, to amend certain terms of the 2022 Private Placement.
On August 19, 2022, 123,504 of the pre-funded warrants were fully exercised at a nominal exercise price of $0.026 per share, which resulted
in an issuance of 123,504 Ordinary Shares.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 30, 2022, in
connection with the closing of the Wellution Acquisition Agreement, we issued the M.R.M Warrant to M.R.M to purchase up to 82,418 of our
Ordinary Shares. As of the date of this Post Effective Amendment, the warrants to purchase up to 82,418 of our Ordinary Shares have been
canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 12, 2023, in connection
with the 2023 Private Placement, we sold units to an institutional investor at a purchase price of $3.72 per unit, consisting of 1,930,108
pre-funded Ordinary Share purchase warrants to purchase up to 1,930,108 Ordinary Shares, and an additional accompanying pre-funded warrant
to purchase up to 1,930,108 Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The pre-funded warrants were
exercisable immediately upon issuance and have an exercise price of $0.001 per share. Following the transaction and as of April 30, 2024,
we have issued 1,587,716 Ordinary Shares in respect of the exercise of 1,587,716 pre-funded warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8. Exhibits and Financial Statement Schedules</B> &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibits:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    No.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    No.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
    Date</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed/<BR>
    Furnished</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023012516/ea172999ex3-1_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Articles of Association of SciSparc Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-269839&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;3.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 16, 2023&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390020007166/ea119823ex99-4_therapix.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant, pursuant to Securities Purchase Agreement, dated March 19, 2020</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 23, 2020</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390020038984/ea130376ex4-2_therapixbio.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 24, 2020</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390021012886/ea136813ex99-4_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2, 2021</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390021012886/ea136813ex99-5_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series A Warrant</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2, 2021</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390021012886/ea136813ex99-6_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Series B Warrant</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 2, 2021</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022030109/ea160740ex99-5_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Ordinary Share Purchase Warrant, pursuant to Securities Purchase Agreement, dated May 27, 2022</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 27, 2022</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022030109/ea160740ex99-6_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Ordinary Share Purchase Warrant, pursuant to Securities Purchase Agreement, dated May 27, 2022</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 27, 2022</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022060388/ea166507ex99-4_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Purchase Warrant, pursuant to Assignment and Assumption Agreement dated September 12, 2022</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30, 2022</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023067123/ea183435ex4-1_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 14, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000101376223003323/ea186598ex4-1_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Pre-Funded Warrant</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 12, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024006291/ea192120ex4-1_scisparc.htm"><FONT STYLE="font-size: 10pt">Form of Promissory Note between SciSparc Ltd. and YA II PN Ltd, which includes the Repayment Schedule (Exhibit 1)</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 25, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391ex5-1_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Meitar Law Offices.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390017004433/f20f2016ex4xii_therapixbio.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indemnification Agreement</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-F</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2017</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390021018407/f20f2020ex4-5_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Exculpation Agreement</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-F</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 30, 2021</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390022022294/f20f2021ex4-3_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation Policy for Executive Officers and Directors</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">20-F</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">April 28, 2022</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4^</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390016019159/ff12016a2ex10i_therapix.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Agreement dated May 20, 2015, by and between the Company and Dekel Pharmaceuticals Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-214458</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 6, 2016</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5^^</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1611746/000121390019008868/f20f2018ex4-2_therapixbio.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License Agreement dated July 29, 2018, by and between the Company and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-F</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 15, 2019</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390016017994/ff12016ex10v_therapix.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Share Option Plan (2015)</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-214458</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 4, 2016</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391ex10-7_scisparcltd.htm"><FONT STYLE="font-size: 10pt">SciSparc Share Incentive Plan (2023)</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-277394</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390020014990/f20f2019ex4-8_therapixbio.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to License Agreement dated as of August 19, 2015, by and between the Company and Dekel Pharmaceuticals Ltd.&nbsp;</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-F</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 15, 2020</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390020014990/f20f2019ex4-9_therapixbio.htm"><FONT STYLE="font-size: 10pt">Third Amendment to License Agreement dated as of July 14, 2019, by and between the Company and Dekel Pharmaceuticals Ltd.&nbsp;</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20-F</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 15, 2020</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 40%"><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390020012970/ea122045ex99-1_therapix.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Transfer Agreement, by and among Capital Point Ltd., Therapix Biosciences, Ltd. and Evero Health Ltd., dated May 15, 2020</FONT></A></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 19, 2020</FONT></TD>
    <TD STYLE="text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 9%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="https://www.sec.gov/Archives/edgar/data/1611746/000121390020012970/ea122045ex99-2_therapix.htm"><FONT STYLE="font-size: 10pt">Asset Purchase Agreement, by and between Therapix Biosciences, Ltd. and Evero Health Ltd., dated May 15, 2020</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 19, 2020</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390020038984/ea130376ex4-1_therapixbio.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agent Agreement, dated November 23, 2020</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 24, 2020</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023014561/ea174175ex99-2_scisparc.htm"><FONT STYLE="font-size: 10pt">Stock Purchase Agreement, dated February 23, 2023, by and between SciSparc Ltd., NewCo Inc. and Jeffs&rsquo; Brands Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023026713/ea176389ex10-2_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum No. 1 to Stock Purchase Agreement, dated March 22, 2023, by and between Jeffs&rsquo; Brands Ltd, Jeffs&rsquo; Brands Holdings Inc. and SciSparc Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023026713/ea176389ex10-3_scisparcltd.htm"><FONT STYLE="font-size: 10pt">Consulting Agreement, dated March 22, 2023, by and between Jeffs&rsquo; Brands Ltd and SciSparc Nutraceuticals Inc.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 4, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390023067123/ea183435ex1-1_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated August 10, 2023, by and between the Company and the Underwriter</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 14, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000101376223003323/ea186598ex10-1_scisparc.htm"><FONT STYLE="font-size: 10pt">Securities Purchase Agreement dated October 11, 2023</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 12, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000101376223003323/ea186598ex10-2_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Rights Agreement dated October 11, 2023</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 12, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000101376223003323/ea186598ex10-3_scisparc.htm"><FONT STYLE="font-size: 10pt">Form of Confession of Judgment</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 12, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000101376223003323/ea186598ex10-4_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter Agreement with Aegis Capital Corp. dated October 10, 2023</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 12, 2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024006291/ea192120ex10-1_scisparc.htm"><FONT STYLE="font-size: 10pt">Standby Equity Purchase Agreement dated January 21, 2024 between YA II PN Ltd. and the Company</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 25, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391ex10-22_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to the Standby Equity Purchase Agreement, dated as of February 26, 2024, between SciSparc Ltd. and YA II PN, Ltd</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-277394</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024032202/ea020369701ex99-1_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement and Plan of Merger, dated April 10, 2024, by and between SciSparc Ltd. with AutoMax Motors Ltd., and SciSparc Merger Sub Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 11, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024032202/ea020369701ex99-2_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Shareholder Support Agreement, dated April 10, 2024, by and between SciSparc Ltd. and each of the parties named in the Shareholder Support Agreement</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6-K</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-38041</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 11, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391ex21-1_scisparcltd.htm"><FONT STYLE="font-size: 10pt">List of Subsidiaries</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333-277394</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 27, 2024</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1&amp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="ea020513701ex23-1_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, independent registered accounting firm for the Registrant.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2&amp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="ea020513701ex23-2_scisparc.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Ben David Shalvi Kop &amp; Co, independent registered accounting firm for AutoMax Motors Ltd.</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391-f1_scisparcltd.htm#b_020"><FONT STYLE="font-size: 10pt">Power of Attorney</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1611746/000121390024017526/ea0200391ex-fee_scisparcltd.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of Registration Fee Table</FONT></A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&amp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Previously filed.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed herewith.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">^</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential treatment was granted with respect to certain portions of this exhibit pursuant to 17.C.F.R. &sect;240.24b-2. Omitted portions were filed separately with the SEC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">^^</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain identified information in the exhibit has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to SciSparc if publicly disclosed.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the registrant is relying on Rule 430B: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness of the date of the first contract or sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date and underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <I>Provided, however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. <I>Provided, however</I>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell securities to such purchaser: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 72px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The undersigned registrant hereby undertakes that: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: 28.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That for purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&nbsp;430A and contained in a form of prospectus filed by the registrant pursuant to Rule&nbsp;424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-indent: 28.35pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">That for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial&nbsp;bona fide&nbsp;offering thereof.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of&nbsp;1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form F-1 and has duly caused this registration statement on Form F-1 to be signed on its behalf by the undersigned, thereunto
duly authorized, in Tel Aviv, State of Israel, on May 2, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SCISPARC LTD.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Oz Adler</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oz Adler </FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 26%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 54%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 18%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Oz Adler&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Chief Financial Officer</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oz Adler</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer and Principal Accounting Officer)</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board of Directors</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amitay Weiss</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amnon Ben Shay</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon Dayan</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moshe Revach</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Itschak Shrem</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liat Sidi</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2, 2024</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lior Vider</FONT></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*By: </FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid">/s/ Oz Adler</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oz Adler </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney-in-Fact </FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE
UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Securities
Act of 1933, as amended, the undersigned, Puglisi &amp; Associates, the duly authorized representative in the United States of SciSparc
Ltd., has signed this registration statement on May 2, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Puglisi &amp; Associates </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><P STYLE="margin: 0pt 0">/s/ Donald Puglisi</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald J. Puglisi </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">II-9</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ea020513701ex23-1_scisparc.htm
<DESCRIPTION>CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 15.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the reference to our firm under
the caption &ldquo;Experts&rdquo; in the Registration Statement on Form F-1 of our report dated April 1, 2024 with respect to the consolidated
financial statements of SciSparc Ltd. (the &ldquo;Company&rdquo;), included in its Annual Report on Form 20-F, as amended, for the year
ended December 31, 2023, filed with the U.S. Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 60%">May 2, 2024</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 40%"><I>/s/ Kost Forer Gabbay &amp; Kaiserer</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Tel-Aviv, Israel</TD>
    <TD STYLE="font-size: 10pt">Kost Forer Gabbay &amp; Kaiserer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Member firm of Ernst &amp; Young Global</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ea020513701ex23-2_scisparc.htm
<DESCRIPTION>CONSENT OF BEN DAVID SHALVI KOP & CO, INDEPENDENT REGISTERED ACCOUNTING FIRM FOR AUTOMAX MOTORS LTD
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="ex23-2_001.jpg" ALT="" STYLE="width: 650px; height: 110px"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="background-color: white">We consent to the incorporation
by reference in this Registration Statement (Form F-1) of SciSparc Ltd. of our report dated March 31, 2024, with respect to the financial
statements of AutoMax Motors Ltd. as of December 31, 2023 and 2022 and the years then ended included in a Report of Foreign Private Issuer
on Form 6-K filed by SciSparc Ltd. with the Securities and Exchange Commission.</FONT> We also consent to the reference to us under the
heading &ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17pt 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Jerusalem, Israel</P>
</TD>
  <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Date: May 2, 2024</P>
</TD>
  <TD><B>By:</B></TD>
    <TD STYLE="padding-bottom: 2pt; border-bottom: Black 1.5pt solid"><IMG SRC="ex23-2_002.jpg" ALT="" STYLE="width: 238px; height: 68px"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
    <TD>Ben David Shalvi Kop &amp; Co.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 17pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex23-2_003.jpg" ALT="" STYLE="width: 650px; height: 90px"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $8 1@# 2(  A$! Q$!_\0
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MT6UTG3HO*M;6,)&O<]R3ZDDDD^I-:=%% !1110 4444 %%%% !1110 4444
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M5ZS0 QE5U*L RD8((R"*BMK:"SMH[:VAC@@C4*D4:A50#H !P!5BB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $+W_D[<?_'*] HH X*W^#?@*VN8KB'0=DL;AT;[9.<,#D'!>N]HHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 4444 %%%% !1110 445S'C7QII_@71XM2U."ZFADF$"K;J&;<03SD@ 84T
M=/17ALGQTUW66:+PMX(N[HY^65]\O'NJ+Q_WU6OX4/Q;U+Q-9ZAX@%K8Z.I)
MFLOD7<"I' 4,V<D'#'M0!ZW7/^+[G6[7PO?3^'+>*XU5%#0Q2J6#<C.!D<XR
M1VR*WQTI: /#-/\ A#XC\77T>J_$76YWP<K8P2 E!Z9 V(.!D(#GU!KU[0]
MTOPYIRV.D6,-I;KR5C7ECZL>K'W/-:M% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5KJSM;U%2ZM
MXIT5@ZK*@8!AT(SWHHH F5%1=J*%7T P*?BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex23-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "B!!8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>/&O!+H8?257_6?+TK_WE[9\NNGVMGZGT3Y_M^G_ ->CS_;]/_KU\Z1?M ?
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M34*T[1M;^\N;R5H_,_M$_9?_ .#=']A[QU\$/A#\1/B!XO\ VG-9UWQ[\+?
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M'.:Y?BEB,ZHX'.*3;<\/B,-1@I1=W;GE1JI6=N5.E**222T37Z9CN#L#B/\
M=,1B,#+O"<ZGX*I3>WGU?H?P2? +_@YP_;*M$D\$_'S2_AAXJM];TDZ/:?$S
M1O#2>&_$GA;4RDB?VPVA:$C^&=>&7#_\(S$8Y=R*#(8]\;_MS^Q9^R9%^VU:
M7/[17QZ\9^(?&WAOQ+='_A$AI&LAAXHTM8Q+KFK-K:D!-";7 WAR*/PPT0:/
MP\2&"\U_,G_P7(_X)W>&/V"?VG;6_P#@S;SVWP1^+>CGQEX1\/KC9\-O$_\
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M2C;L?WAP[POP[PE@U@.&\ERW)<&O^7.7T'1B[;<SE.HW]^H4445R'O!1110
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M?@MKVJ^7M\/_ !1T%QK7A]7UI@TN@>'_ !2T3^$_&<D;M&W@[7KH/\RQJO\
M-5_P;V?\%#?&GP#^)6M?\$Q_VHY-=\/8\2^(M&^$2^*K4Z5J?PU^*$,HD\;_
M  ;)U]E/_".^)O$99_!04GS/&&Z-DE_X2Y%K[O&4J/%V0X7.<+04>)\"FL;@
M4TY8RDH.;K*K&$7!QBN62=*22C4:^%(^#P->KPIFKRS&5+<.2C>&+FG&$9M*
MT7!N:M=V;4[[76K1_<516=#*)<>W(QC_ /7C@_IUJYGA@.F1C\^O//85^=^W
M3>(C&+E/#MIQ>G,[-K6VE[6V?<_1+23]Y)1?VD[_ *?J2T445N!0N?\ 4O\
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MRN0,[$)X'\C?CO3;+1_'GCK2M*@MK;3M*\:>)K*SM+0_\>.F#5VP!VX /4D
M$8'//]6'[.O[77PR_:7\#?VUX7O(--\1VUGJ7]L>#=4NU'B/0G8,A255(.2
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MR6)P[A6<O9-KF/Z"/ ?@'P7\,_#>F^$/!/A[2/#OAJQM!9V6D:9;*D<2 XP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6X/B3Z3L,)E7)PGB))1BX<N38&WO13T<L>^9ZZQ:BXNZ:35E_EUF'AC^SO\
MK>:^V\0LD]LVU)?ZSXIVL_LMY:FUM;=][,^+C_P1^_:!'_,^_#4_2^\4G_W
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M9](WA&AQ'P@N*\!AH3S;*G]:E7HP526;9++XLSO%+V#OROZM^_O9OVUTD_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRA@,C7M \W)+[3(CG/48K\V_B]\3-;^,?Q)\3?$/Q",7_B75A=K9Y)_L_25
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M#O#1U*P\->+_  II.EZ5I%R^L:O*RR:SH4)C;1F\R356FU^6802Q)R$))?\
M8+QS^SYX6\=_%_X7_%W59X_[0^&-CXKMM*\.SZ9I]U8WFH^(M';16D_M=LW$
M1 ;L-V\X"H3M%7XF_LC_  %^+ADN/B%\,O#,^I*-RZSI=L=.\2[>H']NZ%L\
M2 'U$@"\#%?J.?>+O"_&.0Y?PIQ'DU6C@,(W*^#Q,:+N[Q3A2^K0O*TK.TFF
MKR46GI_)5'Z//C+P_P")G%_BIX:>(O!F58C,LXRG,LWX;S!XVODO$*RN#7U>
MI!PI_45B$Y6K*&)=&2@X<ZNGZWX5^,GPP\<6(U+PEX]\+:[;G_E[TKQ'I^I
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M8&,)\HX[G!Z&O,"?D _<<,?I_P#KY_2OZHA_P2]_8TQY2_#/4XAZ)X]^)!!
M]_\ A)5&,#US^53_ /#K[]C7_HF6I?\ A??$?_YIJ_H[+?I/>'V69;ALHP^2
M<2++\)D_]DX?#_45'V:_Z"%)WWN[TTO^WS^ LV_9W^-^?9]BN(\YXUX'QV:8
MS-O[5Q->>.Q<95)-W=%OV,GJU_$=WW@VV6OV$/B;X4\4?LQ_"?1M/U_2+K6/
M!_A/3/"OB.S&I;]1TW5]"C,;>=@$JN"02V -H^88(K[LLQOMA,XM68I^]-N0
M1LR0,8^7)QS@@^I&23\'6?\ P37_ &0["83V'PZU"TG[W-M\1/B;I[_3<GBC
M;V]#SQBOM3P9X6T7P/X8TSPEX<M[FVTG1=+CLM*L[F\U74)$T^$!55Y-9.]F
M7 !5Y'V@[1A#M'\B\2XK*LQS'&XW 7I4,7FM7,XX67ONE[2<ZGL%53AS*$Y)
MJ?LHM\D+QNM?]7_##*^.<AX4R;A[C;*\CGB\IR7)\I6:9=245B?[(RF.5JO+
M!1<U1^L1C[:5*.(J*G>5-3ES<Z\K_: \!?#GXF_#CQ+X9^*,&D77A:YL=M[/
MJEW_ &:MFIY'_$Y=D5&&.&^4X.&R#7\;^HPV^F:IJ-C97YU*WTO6-3^Q:L,#
M[?SUQP#QG\3^-?V(?&;]E_X._M -I\_Q3\*7'B&;2\BR'_"1ZYI84=P!H6OP
MG Z],YZFO A_P3'_ &.K:&&&/X7W\87M:^/_ !C'@\=<^(R0.>N#ZXQ7ZMX-
M^+66^'> SF>8SQ6<2S96H82I%8? 9?9MW>'JRQ$:[>D7[M-MW;=VT?R?]+#Z
M+W''CYFN28OA.'"O#./RB_MLZS3'+!YACT[VO5H8>G5I6U^W6?X)?E-^Q_\
M\%%?$/P9@L? GQ8%SXK^'5N/L.E:LI.H>)?"VEA0HW8'_%0>'P  )  ZJ NX
MJ-I_H ^$GQO^&OQCT4ZU\._%>C>(;(I&TALM1$M_I[$$LNK:2R)/HI5AC]_$
MA. <*",_+4?_  3 _8Y<9/PXU2,<\R>.OB/@D>X\3CZ\5U'@;_@GM^RY\/\
MQ!I_BWPY\/[JS\1Z->:7K%A?W'BWQAJ+1:IHZL(9%2?Q%+&64E<>8CQLP^:,
MC*'YWCGB#PXXCQDLQR/!8C)L6[\[Y(8J$GJ[N$/9Q3ONXR2=[RBW[S^Z\#>"
M?I)>&V'APSQQG/#?$?#D4U3A#,9TL?!-6=LP=/$U+66SIO1))JR1]Y#_ )8?
MC_2K%9T4/EB!1#C[.",]>HZCWZ'V/X8T:_*S^QPHHHH **** "BBB@ HHHH
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MGJER<JYOXD==UW5?%>J:AXC\2:KJ6MZQJI^VWEWJ]Y_:6I<^N1@=3SSBL_\
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M$$:-^Z,K&2K\ /@5\<OBE^QE\:8/$OA#6?AQ\?/AY^V=JG[2?[/=OXC^"K_
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M!%]K7[4OQW_9Q\4_ '1_A]I/AG5]2\26'AK]G3P7X@\ KI'@71O^$='B;7M
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MZ_\ @U;Z:VMWGQ5LO%^BWW@&STD.N_6O^$S2Z;P\=%B#*C7(E* NI#9;:%\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&A4]JJ,>;;II^'KZ#Z***#8**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"JN ..G4Y_S[=O2OGSX]_LR? O]
MJ+P6OP\^/GPO\(?$_P (V^K1>(++1_%.D?;XK'5(U;R]8B!^5=:4L^'51@$<
M-QCZ-HI+GIU55H3]DUNDKW]-5;^NYFJ<72]E/WUK=VM^&OYGC'PG^"GPV^!G
M@K2/AW\)? 'A?X;^ =!79H_A+PCH^FZ=I5B,DDB-<H6_Z:*I<#C?A0!Z9/;+
M+%,+B"VN"W3.1^&3W/3MSCK6W13J3KU*WM?;-?W;-Z]^;FN9TL-2H4?948J"
MZ.R?X>OF8_D>_P"O_P!:C['[?^/5H>1[_K_]:K%+FK_\_G_X#_P33V-#_GU'
M[_\ @&=%:"#C.>/TR?RJZ>$'X8_'G^6:DHH?-*HZDI7NK6M^M_T"G3C35HJU
M]PHHHIF@55E_UH_X#5JB@#RWPWH]MH/C/Q]K9/'BEO"]UQV.D:-_PCN.3_U!
M\XZ]**])^R0^A_,?X44M>KOYV_X(6CTC;[OU19HKD_\ A+O#?W?^$@T/SO[O
M]KIM_+.>G^/M3?\ A-?#'_0Q>'__  <0TP.NHKD?^$V\*_\ 0R>'_P#P;P?X
MU9'BCPW)_P S'H!^FM:6V?\ QX^_ZT =+17-?\);X8_Z&;0O_!SIG_QZC_A+
M?#'_ $,VA?\ @YTS_P"/4 =+17-?\)3X:_Z&3P]_X.]-_P#BJK?\)MX5_P"A
MD\/_ /@W@_QH ZZBN1_X3+PQ_P!#)X?_ /!Q#_\ '*L_\);X8_Z&;0O_  <Z
M9_\ 'J .EHKFO^$M\,?]#-H7_@YTS_X]22>+/"N,GQ+X=_'6M,^G>5O\\4 =
M-17(_P#";>%?^AD\/_\ @W@_QI\7BWPK,./$?AW'_8:TH]_3?0!U=%<U_P )
M1X5_Z&7P]_X.-*_^.T?\);X8_P"AFT+_ ,'.F?\ QZ@#I:*YK_A*?#7_ $,G
MA[_P=Z;_ /%57/C#PO$/^1A\/CZZQ"1W]V]Z .MHKD?^$V\*_P#0R>'_ /P;
MP?XU9_X2WPQ_T,VA?^#G3/\ X]0!TM%<U_PEOAC_ *&;0O\ P<Z9_P#'J/\
MA+?#'_0S:%_X.=,_^/4 =+17(_\ ";>%?^AD\/\ _@W@_P :4>,/"\H_Y&'P
M^?IK$(';W7VH ZVBN:_X2GPU_P!#)X>_\'>F_P#Q5'_"6^&/^AFT+_P<Z9_\
M>H Z6BN:_P"$H\*_]#+X>_\ !QI7_P =J&7Q;X5A'/B/P[C_ +#6E#OZ;Z .
MKHKD?^$V\*_]#)X?_P#!O!_C5B/Q9X5QD>)?#OX:UIGT[2K_ )XH Z:BN:_X
M2WPQ_P!#-H7_ (.=,_\ CU0_\)=X5_Z&3PY_X.]*_P#BZ .KHKD?^$V\*_\
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M8_Z&;0O_  <Z9_\ 'J .EHKFO^$M\,?]#-H7_@YTS_X]1_PEOAC_ *&;0O\
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MTDGBWPW&,GQ)H'T.MZ8I_5Z .FHKD?\ A-O"O_0R>'__  ;P?XT^+Q=X4/\
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M^$M\,?\ 0S:%_P"#G3/_ (]1_P );X8_Z&;0O_!SIG_QZ@#I:*Y3_A+O"O\
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M/^AFT+_P<Z9_\>H_X2SPM_T,WAS_ ,'>F?\ QV@#I:*Y'_A-O"O_ $,GA_\
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M_P#0K^'?_!)IO_R-110 ?\(AX3_Z%?P[_P""33?_ )&H_P"$0\)_]"OX=_\
M!)IO_P C444 '_"(>$_^A7\._P#@DTW_ .1J/^$0\)_]"OX=_P#!)IO_ ,C4
M44 '_"(>$_\ H5_#O_@DTW_Y&H_X1#PG_P!"OX=_\$FF_P#R-110 ?\ "(>$
M_P#H5_#O_@DTW_Y&H_X1#PG_ -"OX=_\$FF__(U%% #O^$3\*_\ 0L^'_P#P
M3:=_\C4W_A$/"?\ T*_AW_P2:;_\C444 '_"(>$_^A7\._\ @DTW_P"1J?\
M\(IX6_Z%K0/_  3Z=_\ (U%% #/^$0\)_P#0K^'?_!)IO_R-3_\ A%/"W_0M
M:!_X)]._^1J** &?\(AX3_Z%?P[_ ."33?\ Y&H_X1#PG_T*_AW_ ,$FF_\
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M?_0K^'?_  2:;_\ (U%% !_PB'A/_H5_#O\ X)--_P#D:C_A$/"?_0K^'?\
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MIO\ \C444 '_  B'A/\ Z%?P[_X)--_^1J/^$0\)_P#0K^'?_!)IO_R-110
M?\(AX3_Z%?P[_P""33?_ )&H_P"$0\)_]"OX=_\ !)IO_P C444 '_"(>$_^
MA7\._P#@DTW_ .1J/^$0\)_]"OX=_P#!)IO_ ,C444 '_"(>$_\ H5_#O_@D
MTW_Y&H_X1#PG_P!"OX=_\$FF_P#R-110 ?\ "(>$_P#H5_#O_@DTW_Y&H_X1
M#PG_ -"OX=_\$FF__(U%% !_PB'A/_H5_#O_ ()--_\ D:C_ (1#PG_T*_AW
M_P $FF__ "-110 ?\(AX3_Z%?P[_ ."33?\ Y&H_X1#PG_T*_AW_ ,$FF_\
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HIO\ \C444 3:7IFFZ;;B+3M/L;"+_GE96D%K'V_@@CC7]**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex23-2_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_002.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !U =8# 2(  A$! Q$!_\0
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MT_5?V@?APGB(Z?+/#'J7AZWL_$VIR:/J;P3V[-IM_J^FZ.;B(%REQ#:2S+'
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MZH3PNX@%CQ@#G+'D8 Y.>F<4SSD5S&[J)-GF"+(\XIEAE81^];)4A0%)8@@
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M.E@<OE&G)XG$KF5>I2HQ;A124INI4IT)_7SSC"QS%Y93Y:F)H495\<J;C*6
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M"[M8[B+CY$_;+_X.%?V>/V=?!O[.7B;X)^$A^T6OQYT/4/%,]AH_B'7/#">
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MH^'6O>')?"=G\6?#WA7Q?J/AGQ)XKT5;/2& MQ8:G+I^FWMHEM?SO=0V/TO
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MKR@JRG(I97@,/EM*M:EA:69N#NK.6*S=U8Q5[:>QJ3FM+N"NKI)G]M?[&O[
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M9NM"TE*\6HMJ3Y>5MWLFWV3_ *$;?_@E7^W/\$OV!_VC?@A^S_XK_9N/Q_\
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M=(M]-TZ*6ZBLX4>2&'=L6"5I9%C$B?F'\=_V[?$?QMU?Q9^S7_P3RTM?C/\
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MUK6? 5OX(^$C^)9(]2L9U\7R>--6\&:7I&J^'+WQ=9Z-! ^K:A^^$]U-&O\
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M%G%I]OIWARTU.VTR-2QEACMHIG>YC!@1,,DC++D_HQ^QO_P;D?M.? CX(_\
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MX7T<>&-*U/P]JUTNL7>G:;JM]*-%_3C_ (*0_P#!J3\+/V]/VNO'?[5'A/\
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M#WGB*^\0:6-&\?:4DVK+;2)=>%[D3:E*@!_KH![=CA75F*[U11ND9,2E9$C
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M=>U73)Y=5AMM3\)V+/))-;Q7-M^P?Q@_;+^//[-'_!UY\,/A/H'QB^*?Q/\
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M -/-+%%'$AN;:1?M!GV1I!YL#/*"C*[QXB_DY_:9_P"#AKXU?L^?\%U?#_\
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M:KI&MZEX9U;2[N?0[Z^CM]1TKQ+HVL>'=3L962ZL->TC5-&NXH=1TZ\MH?\
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M\4^#] UZVTBVO]5TUO'=Y#IK7>FV#WR/9:CKMKIEU=07MK>W4<5YJXM8_$/
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M[2_9WDM8ED"L[O</$BNSE%\S<JQF00ML_EL_X+Q?L#_MC?MB_M7_ +%'BO\
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M\=V]MKWBH?$W3O _BW3=!^)FHQ>&Y_#'B;QIIE]K?@^^\*>$;FQTM/)/C_\
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MR49)!E'1F?0 4444 %%%% !1110 4444 %%%% !1110!_,!_P61^"G_!&?\
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M1?\ !;[Q!\%M&^,W[4>M_!L^#OVBH]?^'O[2GC?Q5;^,KJ_\-:/80W\7Q#\
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M&[S0?M>AZ[=2?VGKWB#P;X\T727\*_$GP?%IEO;>,/!-YKGA)M7T9-=;5[(
M_G$^$'P6^)W[ W_! W3O^"G/[//[27Q1\*_%']LNR^)7[)?B7X9O>ZQ'\/\
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MQIT72/C%X$\7?"N1=.7P1K"?$;2_'5QKO@76)+^>RT?4+2TU66ROY9M*M_\
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MW+)XJ\80>'O&.O>%6O$;Q-K-GJ?AR6RO+B^NOHCXY_\ !JW?Z!^TS9_M'_\
M!.C]MWQU^QE,WPZ\*_#X^&%T7Q-XMUSPW:^&O _AWP+=2:#\38?B-I7BZ?2_
M%EMX>L]4UO1]4EO)=%O9M1CT'59?#5MH'@JP /P;^#7Q,^#>O_\ !M-_P5O^
M$WP7_:._::^+NE?#'QC^P;K>M?!G]HGX7>"O VD_L_:I\0/VF?A7_:8^%VO>
M%OB)\1X?$_A'QUK/@SQ%;WEI<>(/!\>E-X'377^%?@W5/&7BG6=>_-[XP_\
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M<^.Y_&EPVL:AX:C\*CPW/IUOX,LK>X&I/?VNIQ&S6&Y\(_X*0_\ !M'\,O\
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MXWM_">O2>)/B#\.K2'X12V]OINA^'YM3N&&GW.J57_8Q_P""?WPX_P""E/\
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M;Q3_ ,%(_'*Z9^Q1X/\ B]X4T'5=6_9]\.^)K/Q%+\4_B3>^+8-<TO3S\3]
M\4>')_#7P_M/ GP8MM#U?X@>+_"=EX.^'/A&Z\ >'_AQJ4'B9O&6DI)IJ_\
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**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex23-2_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-2_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !M!!D# 2(  A$! Q$!_\0
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MJ7GP2&2.\\X&921@\D8P0<8Q35\(6:6%Q;"\O_.N94EFO/._?NRD$9;'3C&
M,8S70T47861SE_X.L=0EFF-S=0327D=Z)(7 *2)&$&W((Q@=*Z%5VJ!DG'<T
MZBB]P22"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\
MOI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4
M 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GT
MD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/
M^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*
M,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?
M23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\
MOI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4
M 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GT
MD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/
M^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*
M,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?
M23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\
MOI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4
M 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GT
MD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/
M^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*
M,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?
M23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\
MOI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4
M 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GT
MD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/
M^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*
M,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?
M23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\
MOI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4
M 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GT
MD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*,4 5_/E_Y])/
M^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?23_OI?\ &K&*
M,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\ OI?\://E_P"?
M23_OI?\ &K&*,4 5_/E_Y])/^^E_QH\^7_GTD_[Z7_&K&*,4 5_/E_Y])/\
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M!%-R3!19QGB!;:6W\(ZA#:0V\LVIV[9C4 J&1B5R.W3\JL_%7_DG&J>N(_\
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M^E'.A<CN:_AQIG\-:6UQDSFTB,F[KNV#-:E-48]/PIU97N;+0****!A1110
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M%N6N;"U*W#+L,LLSROMZXW.20/:F6GA/2++63JT,,WVWY\227$C@;L;@%9B
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M*TM;UC5=.47%CI$=]9I$99I?M8B9 .3A2IW' SU%5RD\R-^EJ&*198D=?NL
M1QCK7/W^O:I%XB_LK3=(BNU6".>662[$6P,Q7@;3G[IHM<')'345SNK:_>6N
MJ1Z7I>FB_OF@-PZO.(DC3.T'<0>IR,8[52_X3*>>WM(['26FU.Y>9&M))UC$
M1B.)"SX/ )&,#G(HY6',CKZ*Y"3QC<)HTUP-*_XF4-]'8/9O.% D=D P^#E3
MO4YQ5N\U[4M,\+76JZAI,<-S!TM4N]ZL,@#Y]HQU]*.5AS(Z2C-8FFZEJTD5
MQ+K&EPZ>D0W*8[H3;AU/\(QTJCIOB>]N=1M+34-'-E'?HTEI*MP)0X4!L,
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MUI:**DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS1PQJ6/^K8X4#N3_ $KK^,5GVFDVUMJE[J4>[SKX1^:">/D&!BFF)Q9D>'=
M9="1]34_;[NY74+G!Z2[@RK]%PJ_A52QN_[$U/Q->W=I>&&6_C\OR;9Y&<>2
MHW  <C((S[5V.><8I< ]J.8'$YGP7!<"VU2]GMI;9;_4);B*.88<(0 "0>03
0@\5T](."1Z4N:ELI:'__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
